Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Dec 2;16(12):e0260642. doi: 10.1371/journal.pone.0260642

Do manual therapies have a specific autonomic effect? An overview of systematic reviews

Sonia Roura 1,*, Gerard Álvarez 1,2, Ivan Solà 2, Francesco Cerritelli 3
Editor: Andrej M Kielbassa4
PMCID: PMC8638932  PMID: 34855830

Abstract

Background

The impact of manual therapy interventions on the autonomic nervous system have been largely assessed, but with heterogeneous findings regarding the direction of these effects. We conducted an overview of systematic reviews to describe if there is a specific autonomic effect elicited by manual therapy interventions, its relation with the type of technique used and the body region where the intervention was applied.

Methods

We conducted an overview according to a publicly registered protocol. We searched the Cochrane Database of Systematic Reviews, MEDLINE, EPISTEMONIKOS and SCOPUS, from their inception to march 2021. We included systematic reviews for which the primary aim of the intervention was to assess the autonomic effect elicited by a manual therapy intervention in either healthy or symptomatic individuals. Two authors independently applied the selection criteria, assessed risk of bias from the included reviews and extracted data. An established model of generalisation guided the data analysis and interpretation.

Results

We included 12 reviews (5 rated as low risk of bias according the ROBIS tool). The findings showed that manual therapies may have an effect on both sympathetic and parasympathetic systems. However, the results from included reviews were inconsistent due to differences in their methodological rigour and how the effects were measured. The reviews with a lower risk of bias could not discriminate the effects depending on the body region to which the technique was applied.

Conclusion

The magnitude of the specific autonomic effect elicited by manual therapies and its clinical relevance is uncertain. We point out some specific recommendations in order to improve the quality and relevance of future research in this field.

Introduction

The Autonomic Nervous System (ANS) is a system that works involuntarily, maintaining the body’s internal environment (homeostasis) [1, 2]. It is classically differentiated between Sympathetic (SNS), Parasympathetic (PNS), and Enteric branches but from a physiological and neurochemical point of view has five components: the sympathetic noradrenergic system, the sympathetic cholinergic system, the parasympathetic cholinergic system, the sympathetic adrenergic system and the enteric nervous system. These components respond differently depending on the stressors and the pathophysiological states [3]. Several nuclei regulate ANS along the neuraxis, which reacts effectively to many internal (interoceptive) and external (exteroceptive) stimuli. Measuring the ANS within such complexity is challenging. Indeed, several tools and metrics have been developed and used to assess the ANS function [48]. “Table 1”, adapted from Chiera et al. [9], summarises the autonomic markers’ interpretation.

Table 1. Autonomic markers and their interpretation.

Autonomic marker Tool Specific metrics Interpretation
HRV Time-domain
SDNN Standard deviation of NN intervals. It is highly correlated with ULF, VLF and LF. It is more accurate when calculated over 24h. An increase indicates a parasympathetic activation
NN50 Numbers of consecutive NN intervals that differ more than 50ms. An increase indicates a parasympathetic activation
RMSSD Root mean square of consecutive RR intervals. It is considered one of the main measures to assess vagal activity. It is similar to the non-linear metric SD1. An increase indicates a parasympathetic activation
pNN50 Percentage of NN50. It is correlated to RMSSD and HF power. An increase indicates a parasympathetic activation
Frequency-domain
ULF (Power) Ultra-low frequency value. Non-consensus regarding the mechanisms underlying ULF power. Very solo-acting biological processes, such as circadian rhythms, are implicated
VLF (Power) Very low-frequency value. Related to the heart’s intrinsic nervous system, which generates VLF rhythm when afferent sensory cardiac neurons are stimulated. SNS activity due to physical and stress responses influences its oscillations’ amplitude and frequency
LF (Peak, Power, normalised units) Low-frequency value. Non-specific index that reflects baroreceptor activity, it contains contributions of both the sympathetic and parasympathetic influences. High values of LF indicate a sympathetic predominance
HF (Peak, Power, normalised units) High-frequency value. Expression of parasympathetic activity, it corresponds to the HR variations related to the respiratory cycle known as RSA. It changes according to vagal modulation but does not reflect vagal tone. High values of HF indicate a parasympathetic predominance
LF/HF ratio Used to estimate SNS and PNS balance, although LF does not purely represent SNS, and PNS and SNS interact in a complex non-linear manner. A reduction of the LF/HF ratio indicates a sympathovagal balance
Non-linear
SD1 Poincare plot standard deviation. It correlates with baroreflex sensitivity, defined as the change in IBI duration per unit of change of BP, and HF. An increase indicates a parasympathetic activation
SD2 Poincare plot standard deviation. Correlates with LF power and baroreflex sensitivity. High values of LF indicate a sympathetic predominance
SD1/SD2 Ratio between SD1 and SD2, it measures the unpredictability of the RR time series. It correlates with the LF/HF ratio. Values over 1 indicates a parasympathetic effect, whereas values below 1 show a sympathetic effect
DFAα Detrended fluctuation analysis describing short-term (α1) or long-term (β2) fluctuations. It is considered a sensitive parasympathetic index. A decrease indicates a parasympathetic activation
Heart Rate Response to: breathing, Valsalva manoeuvre or postural change The variability of heartbeat is used to assess cardiac sympathovagal function. An increase is considered a sympathetic effect, whereas a reduction shows parasympathetic activation
Blood Pressure Response to: Valsalva manoeuvre, isometric exercise or postural change Variation of blood pressure is utilized to assess adrenergic sympathetic function
Microneurography An electrophysiological technique used for recording single or multi-unit nerve traffic directly from human peripheral nerves. It permits to elucidate and quantify the sympathetic nerve activity in muscle and skin
Spillover urine or plasma A neurochemical technique employed to assess SNS based on the plasma or urine noradrenaline concentration
Pupil Light Reflexes A neurophysiological method assessing the dilation or restriction of the pupil. Parasympathetic action evokes pupil constriction whereas sympathetic noradrenergic activity produces pupil dilatation
Electrodermal activity Galvanic skin response A method utilized to measure neurally-mediated effects on sweat gland permeability—observed as changes in the resistance of the skin. It is considered a reliable measure of sympathetic cholinergic activation
Thermal InfraRed Imaging A method employed to measure the variability of temperature within specific areas of the face. Increase or decrease of the detected temperature implies, respectively, a parasympathetic or sympathetic activity
Skin blood flow Response to: hand grip, cold, heat, baseline variation Different methods are implied. The most common is laser Doppler. It is mainly used to evaluate SNS. A decrease is interpreted as an increase of sympathetic outflow

Manual therapy (MT) is defined as any touch-based conservative treatment approach that includes skilled hands-on techniques to assess and treat different symptoms and conditions using touch as exteroceptive solicitation [10]. It is used by a wide variety of professionals, including physical therapists, osteopaths, and chiropractors, and its use among different age groups and pathologies has been steadily increasing since 2000 [10]. MT includes a wide range of techniques such as soft tissue techniques, joint mobilisations or manipulations, massage, myofascial release, nerve manipulation, strain/counterstrain, and acupressure [1113]. Of note, MT consists of applying these techniques and encompasses a person-centred approach based on a diagnostic clinical reasoning process, a conscientious patient/practitioner interaction and paying attention to patient re-education and advice [12]. The most common complaints treated by MT practitioners are low back and neck pain, sciatica, headache and temporomandibular disorders [1418]. Recent systematic reviews suggest that the MT approach is clinically effective in treating chronic nonspecific neck pain, low back pain and pelvic girdle pain during pregnancy [1921]. Moreover, several clinical studies have shown the effectiveness of MT in a wide variety of clinical conditions, including musculoskeletal pain among different age groups of patients [18, 2227].

Various mechanisms of how MT affects neurobiology have been hypothesised by different researchers, suggesting that the manual solicitations applied by MT intervention produce neurophysiological responses able to modulate the pain experience [12, 2830]. These responses can occur at three levels: 1) peripheral, that is, at the tissue level, where the application of MT induces a modulation of inflammatory response after tissue injury [31, 32]; 2) spinal: mechanical solicitations activate somato-autonomic reflexes, which in turn produce indirect neuromuscular responses and trigger intrinsic spinal networks through spino-spinal loops [33]; and 3) supraspinal, the use of manual contact might regulate brain areas like anterior cingulate cortex, amygdala or periaqueductal grey, which are crucial, for example, in pain experience, autonomic responses and hypoalgesia [28, 29]. Interestingly, these three levels were considered by King and colleagues as the key elements of the autonomic response of MT [34]. Indeed, the authors theorised that these levels are systematically involved during nociception, pain and inflammation [34]. It has been hypothesised that the effects induced by manual solicitations are dependent upon a specific type of touch, namely affective touch [35]. This gentle solicitation selectively activates low mechanical threshold C fibres [named C-tactile fibres or CTs] [3539], which produce a specific activation of autonomic supraspinal nuclei as well as brain areas regulating emotions and interoception [36, 37, 39, 40]. Initial evidence suggests that MT interventions cause changes in different autonomic markers [4149] and a recent paper has introduced the potential preventive role of MT in ANS imbalance [50]. However, the precise mechanisms by which MT interventions activate the autonomic response are still under exploration [50].

It is well-known that a balanced ANS function is generally associated with health [50], while impairments in autonomic regulation have been considered a risk factor for physical and psychological morbidities and pathologies (e.g., hypertension, persistent generalising pain disorders, rheumatic diseases, diabetes or depression) [34, 51, 52]. It is worth noting that these clinical conditions are classified as dysautonomic, which means that they are generally associated with an increased sympathetic or decreased parasympathetic vagal activity. A recent systematic review (SR) investigated whether heart rate variability (HRV) parameters are altered in people with chronic low back pain when compared to healthy controls, showed that patients with chronic low back pain have a significant reduction in HRV, with sympathetic predominance compared to healthy controls [53].

Evidence about autonomic effects of manual therapy interventions is synthesised within many reviews [43, 45, 46, 49]. However, no clear conclusions have been yielded, and a comprehensive overview of systematic reviews in this area is currently lacking.

Considering the effects of MT on ANS function and the ANS role in pathologies, it is paramount to understand the potential effect of MT on ANS, which could be used as an adjunct therapy, even prevention, for diseases associated with autonomic imbalance.

This overview aims at describing if there is a specific autonomic effect elicited by MT interventions, its relation with the type of technique used and the body region where the MT was applied. The paper also explores how the effects reported are related to the measures used to assess the ANS and, eventually, the clinical relevance and applicability of the results. Finally, the review proposes some recommendations for future research in the field.

Objectives

This overview aims to summarise the evidence published in SRs on the autonomic effects of MT interventions in either healthy or symptomatic populations. To this end, the proposed overview will answer the following questions:

  1. Is there a specific autonomic effect observed after manual therapy interventions?

  2. Different types of manual techniques elicit different autonomic effects?

  3. Does the body region where the manual therapy is applied influence the autonomic outflow?

  4. What are autonomic measures used to assess the autonomic effect elicited by manual therapy interventions?

  5. Are the effects of MT on ANS clinically relevant?

Materials and methods

The scope of this overview was to summarize systematic reviews with the primary aim of assessing the autonomic effect elicited by an MT intervention in either healthy or symptomatic populations, irrespective of their age.

According to a protocol registered at the Open Science Framework (DOI 10.17605/OSF.IO/TX69Y), we conducted an overview of systematic reviews that adhered standardised methodological guidance [54, 55]. As reporting standards for overviews are still under development [54] we report the findings of our study adhering the applicable items from the PRISMA statement [56].

Inclusion criteria

We included systematic reviews that were defined according the following specific criteria [57].

  1. provided specific eligibility criteria allowing to define the clinical question to be addressed in this overview [58]

  2. described a search strategy in at least two information sources [59]

  3. included a formal assessment of the risk of bias for the studies included in the review [58]

We defined the following criteria to answer the research question:

Eligible reviews had to include studies in healthy or symptomatic populations irrespective of their gender and age. Those studies had to assess the impact of any type of MT intervention isolated or in combination with additional interventions, compared to any type of control intervention (usual care, placebo or active interventions).

We defined MT as any touch-based intervention delivered with therapeutic intent. We used a standardised glossary to classify the MT techniques assessed in the eligible reviews [60]: mobilisations [passive movements that consist of oscillatory techniques and low frequency/high amplitude techniques], manipulations (encompass spinal manipulative treatment, high-velocity low amplitude techniques, thrust techniques), myofascial techniques, balance ligamentous techniques, balance membranous techniques, cranial techniques, and soft tissue techniques (i.e. massage, passive stretching).

We included isolated interventions assessing an autonomic effect and combinations of techniques/approaches of manual interventions. We excluded packages of care where manual therapy was in combination with other therapies (i.e. exercises, cognitive education). We also excluded SRs assessing the effects of different interventions (not only MT) on an autonomic outcome. We limited eligibility to reviews focused on human studies and published in the English language.

The primary outcome for the overview was to assess the autonomic effect resulting from the MT intervention measured by the reaction of the SNS, PNS and /or the balance between SNS and PNS activity. For synthesis and analysis within the overview, the outcomes had to be measured using markers of autonomic response as described in “Table 1”. Our secondary outcome of interest was to describe the clinical relevance of the results assessed by the outcomes related to pain improvement or any other patient-related outcomes (PROMS) reported in the included reviews.

Search methods for identification of the reviews

We searched the Cochrane Database of Systematic Reviews (The Cochrane Library), MEDLINE (PubMed), EPISTEMONIKOS and SCOPUS from inception to March 2021. We designed search strategies tailored to the requirements of each database, combining terms from their controlled vocabulary (e.g. MeSH terms in MEDLINE) and text terms related to ANS and MT interventions. We report the MEDLINE search strategy included in “S1 Table”.

Additionally, we tracked back and forwarded references and citations for the relevant studies through the Web of Science (Clarivate).

Data collection and analysis

Selection of reviews

Two authors (SR and GA) independently assessed titles and abstracts of records identified by the electronic searches according to the inclusion criteria and decided on eligibility obtaining a full-text copy from relevant references.

We solved disagreements involving a third author (FC) to reach a consensus through discussion.

Data extraction and assessment of the methodological quality of the included reviews

Two overview authors (SR and GA) extracted data independently and discussed discrepancies until a consensus was reached. We planned in the protocol to involve a third author (FC) to solve disagreements. We used a data collection form specifically designed and piloted for the overview purposes (“S2 Table”).

We extracted data on the following key features of each review:

  1. identification elements (Title, author, year of publication, journal, number and type of articles included).

  2. the characteristics of the patients included (healthy or symptomatic, age, gender), the generic and the name of the experimental intervention, the type of control used, number of sessions and duration of treatment and follow-up, outcome measures and the autonomic marker used.

  3. Autonomic effect, duration of the effect (for this review, the effects were classified considering time as follows: short-term effect (immediately after the intervention), medium-term effect (from 1 to 24 weeks) and a long-term effect (more than 24 weeks) [6163]), and hypothesis for effect found.

  4. PROMS associated with the autonomic effect, contextual and confounding factors reported.

  5. Design or reporting guidelines used and limitations and implications for future research if reported.

Using an Excel spreadsheet, we mapped the studies included within each included review to explore their overlap. We used the GROOVE tool [64] to assess the percentage of overlap among reviews. Percentage of the corrected covered area (CCA) was calculated considering: CCA <5% (slight overlap); CCA 5 - <10% (moderate overlap); CCA 10 - <15% (high overlap); CCA >15% (very high overlap).

We also used the GROOVE tool to decide which reviews should inform the overview findings and assess the degree of concordance among reviews conclusions.

Data from the primary studies of each SR (as documented in the published SRs) was extracted, including participants, intervention, comparison, outcome assessment, results and quality assessment.

Two authors (SR and GA) independently used the ROBIS tool [65] to appraise the methodological quality of the included reviews.

Data analysis and synthesis

We synthesised in tables the included reviews characteristics and summarised findings narratively according to quality and outcomes of interest for the overview. We calculated the overlap between the included reviews according to the percentage of the corrected covered area [64].

Initially, we planned to perform a meta-analysis according to a two-step frequentist approach (random-effects model) with continuous end-point data for each outcome in R statistical software. We planned to assess within- and across-condition heterogeneity with the I2 statistic, setting a threshold of < 75%, to make the decision to pool the estimates across 1) the within condition reviews and 2) across the condition estimates. We planned to express effect estimates in standardised mean differences with 95% confidence intervals for all analyses. We also planned to conduct Egger’s test to detect publication bias in those analyses, including more than 10 studies. Finally, we anticipated in our protocol to explore subgroup effects according to the ages of participants (children and adolescents, adults, older adults), type of manual therapy intervention, comparator groups and duration of follow-up. The heterogeneity between studies did not allow us to perform pooled analysis.

Generalisation of the evidence

We discussed on the generalisability of the overview findings and the applicability of the body of primary research assessed through the included reviews. We analysed and interpreted the data obtained from the included reviews and classified them around a list of predefined questions which we anticipated to be relevant:

  1. Is there evidence of a general autonomic effect of manual therapy interventions across reviews?

  2. Had this effect a specific ANS direction (i.e. sympathetic, parasympathetic)?

  3. Is there evidence of the relation between the autonomic effect and the decrease of pain or any other clinical outcome?

  4. Is this effect different when using an isolated MT technique or combining different MT techniques/approaches?

  5. Is the effect robust across conditions, type of interventions and age groups?

  6. Is the body region where the technique is applied important to observe any specific effect?

  7. Is there evidence for the duration of the autonomic effect? (short, medium or long-term effect)

  8. Do the contextual factors and/or the non-specific effects of MT interventions influence the autonomic effects?

  9. Can we infer that the effect might be observed across conditions not included in the current overview?

To respond to these questions we considered the findings of both the included reviews and the assessed primary studies, their methodological quality, their conclusions and the limitations and implications for future research highlighted within the reviews.

Results

Search results and study eligibility

The search yielded 557 records (383 from MEDLINE, 1 from the CDSR, 35 from EPISTEMONIKOS and 138 from SCOPUS), from which we selected 17 reviews for a detailed assessment. We excluded 5 reviews for the following reasons: one for the research design [66], two that did not include a quality assessment of the primary studies [42, 67], one did not fulfil the outcome established for this overview [68], and one included a combination of different types of interventions [69]. As a result of the eligibility process, we included 12 systematic reviews in the overview. We display the complete process in a flowchart (Fig 1).

Fig 1. PRISMA flowchart.

Fig 1

Characteristics of included reviews

Characteristics of included reviews are shown in “Table 2” and reported as follows:

Table 2. Characteristics of the included reviews.

Included review DESIGN POPULATION INTERVENTION FINDINGS
Wirth 2019 Risk of bias (ROBIS) low
Search date July 2018
Study design controlled studies
Included studies 18
Quality / bias approach score (Downs and Black)
Meta-analysis no
Assessed quality of evidence no
healthy volunteers, patients with pain in different locations and of different chronicity Intervention
HVLA-SMT
Comparison
inactive control or placebo
Measure
HRV, BP, SC, O2 saturation, pupillometry
Effect
changes in ANS, changes in heart rate variability and skin conductance, and the direction of effects depending on body region
Picchiotino 2019 Risk of bias (ROBIS) low
Search date July 2018
Study design sham controlled trials
Included studies 29
Quality / bias approach domains (Cochrane RoB tool)
Meta-analysis yes
Assessed quality of evidence yes
healthy volunteers and symptomatic patients Intervention
JMT applied on spinal or peripheral joints
Comparison
sham techniques
Measure
SC, ST, SBF, HR, HRV, RR, PB, PC, pupilometry
Effect
sympathetic effect on the skin for mobilizations regardless the area treated, not in other autonomic markers
Rechberger 2019 Risk of bias (ROBIS) unclear
Search date April 2018
Study design any design
Included studies 23
Quality / bias approach score (Downs and Black, Kienle)
Meta-analysis no
Assessed quality of evidence no
healthy volunteers, craniofascial pain, temporomandibular dysfunction, hypertensive, lumbar pain, neck pain, headache Intervention
HVLA techniques, mobilizations, functional and cranial
Comparison
inactive control or placebo
Measure
PC, BP, HR, SBF
Effect
changes in ANS
Navarro-Santana 2019 Risk of bias (ROBIS) unclear
Search date March 2018
Study design RCT
Included studies 18
Quality / bias approach domains (Cochrane RoB tool)
Meta-analysis yes
Assessed quality of evidence yes
healthy volunteers, elbow pain, neck pain, craniofacial pain Intervention
mobilization techniques
Comparison
placebo, sham or no intervention
Measure
SC, ST
Effect
sympathetic-excitatory effect
Araujo 2018 Risk of bias (ROBIS) low
Search date March 2014
Study design RCT
Included studies 18
Quality / bias approach score (PEDro score)
Meta-analysis no
Assessed quality of evidence yes
healthy volunteers and symptomatic patients Intervention
spinal mobilizations and manipulations
Comparison
inactive control, placebo or other SMT techniques
Measure
SC, ST, HR, pupilometry
Effect
uncertain
Amoroso Borges 2018 Risk of bias (ROBIS) unclear
Search date December 2016
Study design RCT
Included studies 10
Quality / bias approach score (PEDro score)
Meta-analysis no
Assessed quality of evidence
healthy volunteers Intervention
spinal manipulation and myofascial techniques
Comparison
inactive control or placebo
Measure
HRV
Effect
changes in ANS
Galindez 2017 Risk of bias (ROBIS) unclear
Search date August 2016
Study design RCT
Included studies 11
Quality / bias approach score (Cochrane Back Review tool)
Meta-analysis no
Assessed quality of evidence no
healthy volunteers and symptomatic patients Intervention
cervical HVLA manipulation techniques
Comparison
any placebo, sham techniques, manual contact, quite rest
Measure
ECG: HR, BP, oxygen saturation
Effect
a decrease in diastolic BP was found; heart rate, systolic BP, electrocardiogram, and bilateral pulse oximetry, the changes were not significant
Lascurain 2016 Risk of bias (ROBIS) high
Search date not reported
Study design RCT, controlled trials and case control studies
Included studies 24
Quality / bias approach score (Cochrane Back Review tool)
Meta-analysis no
Assessed quality of evidence no
symptomatic patients (neck pain, lumbar pain, cervicobrachial neurogenic pain,shoulder, elbow, craniofacial pain) Intervention
spinal manipulation
Comparison
placebo, inactive control or no intervention
Measure
SC, RR, HR, ST
Effect
increase SC, HR, RR, decrease or no change in ST
Chu 2014 Risk of bias (ROBIS) low
Search date not reported
Study design RCT
Included studies 11
Quality / bias approach score (PEDro score)
Meta-analysis yes
Assessed quality of evidence no
healthy volunteers and chronic lateral epicondylalgia,cervico-craniofacial pain and nonacute cervicobrachial neurogenic pain. Intervention
SMT to the cervical or thoracic spine segments
Comparison
not described
Measure
SC, ST, pain, ROM
Effect
sympathetic-excitatory effect
Kinsgton 2014 Risk of bias (ROBIS) unclear
Search date May 2012
Study design RCT
Included studies 7
Quality / bias approach mixed (Cochrane RoB tool / PEDro score)
Meta-analysis no
Assessed quality of evidence no
healthy volunteers and symptomatic patients Intervention
spinal mobilization
Comparison
placebo, inactive control or no intervention
Measure
SC, ST, HR, RR, BP
Effect
sympathetic-excitatory effect
Hegedus 2011 Risk of bias (ROBIS) unclear
Search date November 2010
Study design controlled trials
Included studies 10
Quality / bias approach score (Cochrane Back Review tool)
Meta-analysis no
Assessed quality of evidence yes
healthy volunteers and symptomatic patients Intervention
spinal mobilization
Comparison
not described
Measure
SC, ST
Effect
sympathetic-excitatory effect
Schmid 2008 Risk of bias (ROBIS) unclear
Search date November 2007
Study design RCT
Included studies 15
Quality / bias approach score (Cochrane Back Review tool)
Meta-analysis no
Assessed quality of evidence no
healthy volunteers and symptomatic patients (neck or upper limb) Intervention
passive accessory cervical joint mobilisation techniques
Comparison
one or two control conditions, receiving either manual contact, no contact or therapeutic ultrasound interventions
Measure
SC, BP, HR, RR
Effect
sympathetic nervous system excitation (increase SC, no effect on ST)

RCTs: randomized clinical trials; CTs: clinical trials; HVLA: high velocity low amplitude techniques: SMT: spinal manipulative therapy; JMT: joint manipulative therapy; HRV: heart rate variability; SC: skin conductance; ST: skin temperature; HR: heart rate; RR: respiratory rate; BP: blood pressure; ROM: range of movement; ECG: electrocardiogram; SBF: skin blood flow; ANS: autonomic nervous system.

Types of studies

All the reviews included randomized clinical trials (RCTs), one also included quasi-RCTs, four included non-randomized trials and two other designs.

There were 194 primary studies included in the 12 reviews. Considering duplicates, a total of 101 primary articles were analyzed. Because 39 of these primary studies did not assess the ANS, the analysis was conducted using 62 studies (enrolling 2201 participants).

Participants

Ten out of 12 reviews included both genders and adult healthy and symptomatic participants, whereas two included only adult symptomatic participants [43, 70]. Specific conditions varied among reviews and included: lateral epicondylalgia, cervical pain, cervicobrachial pain, craniofacial pain, lumbar pain, shoulder pain, elbow pain and hypertensive subjects.

Interventions

Nine out of 12 reviews included spinal mobilizations [4345, 4749, 7173], of which only one focused on the cervical spine [72]. Seven reviews included spinal manipulations [41, 45, 46, 48, 49, 70, 72]. Three included cranial techniques [44, 48, 71], two myofascial techniques [44, 48] and one peripheral mobilizations [46]. A list of the body regions where the studies were focused can be found in “Table 3”.

Table 3. Body regions where the studies were focused.

Body region Systematic Reviews
Spine (all regions) Hegedus 2011, Kingston 2014, Amoroso 2018, Araujo 2018 Navarro 2019, Picchiottino 2019, Wirth 2019
Only cervical spinal Schmid 2008, Lascurain-Aguirrebeña 2016, Galindez-Ibarbengoetxea 2017
Cervical and thoracic spine Chu 2014
Peripheral joints Navarro-Santana 2019, Picchiottino 2019
All body regions Rechberger 2019

Most of the reviews assessed the autonomic effect of a single isolated technique. One of the 12 reviews included studies combining different techniques as a therapeutic approach (manipulations, mobilizations, myofascial and cranial techniques) [48].

Comparisons

Included reviews explored comparisons of interventions with no treatment, placebo/sham or other interventions. Seventy-five per cent of the included studies used a placebo/sham comparator. Comparison groups included within each review are summarized in “Table 2”.

Outcomes

Included reviews covered a wide range of outcomes. Three reviews assessed the autonomic skin activity only [43, 46, 73]. One assessed only cardiovascular autonomic activity [44]. The rest combined different assessments, including skin and cardiovascular activity, pupil autonomic control and sympatho-adrenal activity.

The autonomic markers included in the reviews were: Skin conductance -SC- was the most frequent marker used (9/12; 75%), followed by skin temperature -ST- (8/12; 67%), heart rate -HR- (7/12; 59%), blood pressure -BP- (6/12; 50%), heart rate variability -HRV- (4/12; 33%), respiratory rate -RR- (4/12; 33%), pupillometry (4/12; 33%), oxygen saturation (3/12; 25%), plasma catecholamine -PC- (2/12; 17%) and skin blow flow -SBF- (1/12; 8%). When exploring the primary studies included in the reviews, the most frequent autonomic markers were SC (32%) and HRV (31%).

These markers were used to measure skin autonomic activity (SC, ST, SBF), cardiovascular autonomic activity (HRV, BP, HR, oxygen saturation), pupil autonomic regulation and sympatho-adrenal system (PC). Cardiovascular autonomic regulation was the most frequently assessed (48% of the primary studies), followed by skin autonomic activity (37%).

Seven of the 12 reviews included multiple assessments of the ANS. Moreover, 5% of the primary studies assessed also PROMS with pain measurements.

Risk of bias of included reviews

Five of the included reviews were assessed as low risk of bias (RoB) using the ROBIS tool, six scored unclear RoB and one high RoB, as summarised in “Table 4”. Details of this assessment can be found in “S3 Table”.

Table 4. Risk of bias of included reviews (ROBIS assessments).

REVIEW 1. Concerns regarding specification of STUDY ELEGIBILITY CRITERIA 2. Concerns regarding methods used for the IDENTIFICATION AND SELECTION OF STUDIES 3. Concerns regarding methods used in DATA COLLECTION AND STUDY APPRAISAL 4. Concerns regarding methods used in SYNTHESIS AND FINDINGS RISK OF BIAS IN THE REVIEW
Wirth 2019 low low low low LOW
Picchiotino 2019 low low low low LOW
Araujo 2018 low low low low LOW
Chu 2014 low low low low LOW
Navarro-Santana 2019 unclear low low unclear UNCLEAR
Hegedus 2011 unclear low low unclear UNCLEAR
Rechberger 2019 low unclear unclear unclear UNCLEAR
Galindez 2017 low unclear unclear unclear UNCLEAR
Kinsgton 2014 low unclear low high UNCLEAR
Amoroso Borges 2018 low unclear unclear high UNCLEAR
Schimid 2008 low low low high UNCLEAR
Lascurain 2016 unclear unclear low high HIGH

Four SRs reported a GRADE assessment of the certainty of the evidence of their included studies [45, 46, 49, 73]. In general, low to very low was the most rated quality of evidence for the autonomic effects of MT interventions and moderate evidence for mobilizations.

Overlap between included reviews

Fig 2” displays the overlap between the included reviews through the percentage of the corrected covered area and the studies overlapping in the included reviews. We observed a high overlap between the reviews that ranged from 10% to more than 15% CCA. We analyzed in detail this overlap in the discussion.

Fig 2. Overlapping ANS outcomes.

Fig 2

Overlapping of the included reviews.

Findings from the included reviews related to the autonomic effects of interventions, techniques used and the autonomic markers

The findings and conclusions of the included reviews are summarized in “Table 5”. For those reviews that used GRADE we also show their judgements on the certainty of evidence. The concordance between the findings of the reviews with a high degree of overlap can be seen in “S4 Table”. Eleven of the twelve reviews specifically addressed acute autonomic effects. Skin conductance was the only autonomic marker that demonstrated a consistent acute sympatico-excitatory effect, but only for spinal mobilisations, not for other techniques.

Table 5. Techniques, autonomic markers used and autonomic effects of included reviews.

Review Technique Measure Effect GRADE Assessment
Wirth 2019
HVLA upper cervical HRV Increase PNS activity NO
BP reduction systolic BP, no effect
HVLA lower cervical SC Increase SNS activity
HRV Increase SNS activity
PB reduction systolic BP, no effect
HVLA upper thoracic HRV Increase SNS activity
Oxygen saturation no effect
Pupillometry no effect
HVLA lumbar SC Increase SNS activity (healthy)/ increase PNS activity (LBP)
General conclusion: changes in ANS associated with HVLA-SMT in pain patients, but the direction of change is not consistent across studies. Recommendations: baseline values of outcome measures and to link neurophysiological HVLA-SMT effects to changes in perceived pain
Picchiottino 2019
Mobilisations (oscillatory) SC Increase SNS activity (moderate evidence) Moderate-certainty evidence (SC)
ST no effect (no good markers for SNS skin activity)
SBF modulate or no effect
HR no acute effect / increase systolic BP
HRV no acute effect
RR increase RR (low evidence)
Mobilisations (movement) SC/ST (spinal) no acute effect
SC (peripheric) increase SNS activity (low evidence)
ST/SBF modulate SNS activity (very low evidence)
HR/BP modulate SNS activity (very low evidence)
HVLA HRV no acute effect
HR no acute effect
BP no acute effect
pupil diameter no acute effect
PC no acute effect
General conclusion: Contradictory, Uncertain and inconclusive because of low evidence and limited clinical relevance. Moderate evidence for sympathetic-excitatory effect after mobilizations regardless of the body region
General recommendation: Increase methodological quality, long-term effects and measures with pain, assess in chronic pain
Araujo 2019
Mobilisations SC increase, increase SNS activity Very low-low evidence
ST chronic pain decrease, increase SNS activity
HR increase, increase SNS activity
Manipulations pupil diameter no effect (vs placebo)/ decrease diameter (vs no treatment)
General conclusion: Conflicting results, no clinical improvement
Recommendations: Increase quality and reporting, long-term follow up
Chu 2014
Spinal MT on cervical pain SC increase, increase SNS activity NO
ST decrease, increase SNS activity
Spinal MT on lumbar pain SC increase, increase SNS activity
ST decrease, increase SNS activity
General conclusion: Sympatico excitatory but challenges for the current understanding of skin nervous activity (local endothelial mechanisms)
Recommendations: Palpatory findings + pain scale, recommendations for using laser Doppler Flowmetry
Navarro-Santana 2019
Mobilisations SC increase, increase SNS activity Very low-moderate evidence
ST decrease, increase SNS activity
General conclusion: Heterogeneity, Results suggests a sympathetic effect (SC, ST) after mobilization. The authors used GRADE and rated the results as moderate certainty (or quality) of evidence.
Recommendations: Use of different manual therapy approaches, Association with treatment benefits
Hegedus 2011
Spinal mobilisations ST No change Very low-low evidence
SC increase, increase SNS activity
General conclusion: Sympatico excitatory effect
Recommendations: Randomized controlled trials on subjects with pain and decreased function
Rechberger 2019
HVLA cervical HRV Significant change, no conclusion NO
HVLA lumbar HRV Increase PNS activity
Cranial HRV Increase PNS activity
PC +BP +HR No effect
SBF slight reduction SNS activity
Mobilization thoracic pain assessment reduction in pain because of SNS changes
SC Increase SNS activity
HRV change in ANS
General conclusion: Changes in ANS but the direction of change is not consistent across studies. Inconclusive results
Recommendations: Increase the number of participants in studies. Increase methodological quality
Galindez 2017
Cervical HVLA BP Decrease in Systolic BP in hypertensive I, no effect in healthy subjects NO
HR No effect
Oxygen saturation No effect
General conclusions: A decrease in diastolic BP was found; however, for other studied variables, such as heart rate, systolic BP, electrocardiogram, and bilateral pulse oximetry, the changes were not significant
Recommendations: not reported
Kingston 2014
Spinal mobilisations ST decrease, increase SNS activity NO
SC increase, increase SNS activity
RR increase, increase SNS activity
HR increase, increase SNS activity
BP increase, increase SNS activity
General conclusion: Sympatico excitatory effect
Recommendations: symptomatic population
Amoroso-Borges 2018
Manipulation cervical and lumbar HRV increase PNS activity NO
Manipulation thoracic HRV increase PNS activity
Myofascial HRV increase PNS activity
Cranial HRV increase PNS activity
General conclusion: PNS response when stimulation was performed in the cervical and lumbar regions, SNS response when stimulation was performed in the thoracic region
Recommendations: Long-term effects
Schmid 2008
Cervical mobilizations SC increase, increase SNS activity NO
SBF Increase in the elbow, decrease in the hand, increase SNS activity
HR increase, increase SNS activity
BP Increase diastolic BP, increase SNS activity
ST Conflicting evidence
General conclusions: Sympatico excitatory effect after cervical mobilisation regardless of the body segment receiving the treatment.
Recommendations: To include outcome measures designed to evaluate the multisystem effects of treatment. Better reporting in order to facilitate future meta-analysis and comparison of results.
Lascurain 2016
Mobilizations SC increase, increase SNS activity NO
HR increase, increase SNS activity
RR increase, increase SNS activity
ST No effect
SBF decrease, increase SNS activity
General conclusion: Sympathoexcitation after mobilizations
Recommendations: To observe possible mechanisms of action and symptom reduction in patients.

SNS: sympathetic nervous system; PNS: parasympathetic nervous system; HVLA: high-velocity low amplitude; HRV: heart rate variability; PC: plasma catecholamine; SC: skin conductance; ST: skin temperature; SBF: skin blow flow; RR: respiratory rate; HR: heart rate; BP: blood pressure; MT: manual therapy; SMT: spinal manipulative therapy; LBP: low back pain.

Autonomic effects and techniques

MT techniques eliciting PNS or SNS changes were different, as shown in “Table 5”.

Ten out of 12 SRs concluded that mobilisations and manipulations have a sympathetic-excitatory effect on sympathetic skin activity [41, 43, 4549, 70, 72, 73]. Confirmatory results were also shown using other autonomic markers [41]. One study concluded that mobilisations have an SNS effect at the skin level but not when assessing other systems, such as cardiovascular and respiratory [45]. One SR found a PNS effect on the cardiovascular system after different MT interventions [44, 47]. Two SRs differentiated the effect of MT interventions (sympathetic or parasympathetic) depending on the area of the spine where the intervention was performed [44, 47]. One SR claimed that MT interventions elicit changes on ANS [48]. However, the authors did not mention either the direction of changes or any effect associated with body regions [48].

Autonomic effects and autonomic markers

Assessing ANS with skin autonomic markers. Ten SRs included autonomic skin markers to assess ANS activity [41, 43, 4549, 70, 72, 73]. SC was used in all the articles and ST on eight SRs. Skin blood flow assessed with laser doppler flowmetry was used in two SRs (“Table 6”).

Table 6. Skin autonomic markers among the included studies.
Skin marker Technique Result autonomic effect Article
SC HVLA lumbar increase SNS effect Wirth 2019
mobilisations (oscillatory) increase SNS effect Picchiottino 2019
spinal mobilizations (movement) increase SNS effect Picchiottino 2019, Navarro-Santana 2019, Araujo 2019, Kingston 2014, Lascurain 2016, Schmid 2008, Hegedus 2011
peripheral mobilisation increase SNS effect Picchiottino2019, Navarro-Santana 2019. 
spinal manual therapy increase SNS effect Chu 2014
ST mobilisations (oscillatory) no effect no effect Picchiottino 2019
spinal mobilisations (movement) no effect no effect Picchiottino 2019, Hegedus 2011, Lascurain 2016
decrease SNS effect Navarro-Santana 2019, Araujo 2019, Kingston 2014
Conflicting evidence Schmid 2008
peripheral mobilisation decrease SNS effect Picchiottino 2019, Navarro-Santana 2019
spinal manual therapy decrease SNS effect Chu 2014
Skin blood flow (LDF) mobilisations (oscillatory) no effect no effect Picchiottino 2019
peripheral mobilisation increase SNS effect Picchiottino 2019
Cervical mobilizations Increase in the elbow SNS effect Schmid 2008
decrease in the hand PNS effect

SC: skin conductance; ST: skin temperature; SBF: skin blood flow; HVLA: high velocity/low amplitude; SNS: sympathetic; PNS: parasympathetic; LDF: laser doppler flowmetry.

All articles assessing SC showed an increase suggesting an SNS effect after manipulation, mobilization and myofascial techniques [41, 43, 4547, 49, 70, 72, 73]. When assessing ST, most authors found a reduction after mobilisations in different body regions [41, 43, 46, 49]. Two reviews did not find any effect of mobilisations on ST [45, 70], and one found conflicting evidence [72]. Conversely, two SRs assessed autonomic skin activity by SBF. One showed an increase in blood flow when applying cervical mobilisations [72], and the other found an increase in blood flow when using peripheral mobilisations but no effect after spinal mobilisations [45].

Assessing ANS with HRV. Four SRs used HRV to assess ANS activity [44, 45, 47, 48]. Although one SR did not specify which markers were used to assess HRV, three SRs reported results on different HRV domains and metrics (“Table 7”)—for a more comprehensive description of these metrics see [8, 9]-. In general, all the studies reported short-term measurements of HRV. Any of the reviews included linear and non-linear measurements.

Table 7. Short-term effects of different techniques on specific autonomic indices of HRV.
HRV marker Technique Result autonomic effect Article
Time-domain
SDNN Myofascial increase PNS activation Amoroso-Borges 2018
RMSSD Myofascial increase PNS activation Amoroso-Borges 2018
pNN50 Myofascial increase PNS activation Amoroso-Borges 2018
Frequency domain
LF HVLA upper thoracic increase SNS predominance Wirth 2019
HVLA lower cervical increase SNS predominance Wirth 2019
HF HVLA upper thoracic decrease Decreased PNS predominance Wirth 2019
HVLA lower cervical decrease Decreased PNS predominance Wirth 2019
HVLA upper cervical increase PNS predominance Amoroso-Borges 2018
Myofascial increase PNS predominance Amoroso-Borges 2018
Spinal manipulation No effect No effect Picchiottino 2019
LF/HF ratio HVLA upper thoracic increase increased sympa- tho-vagal balance Wirth 2019, Amoroso-Borges 2018
HVLA lower cervical increase increased sympatho-vagal balance Wirth 2019
HVLA upper cervical decrease sympatho-vagal balance Wirth 2019, Amoroso-Borges 2018
HVLA lumbar decrease sympatho-vagal balance Amoroso-Borges 2018
Myofascial decrease sympatho-vagal balance Amoroso-Borges 2018
Spinal Manipulations No effect No effect Picchiottino 2019

SDNN: the standard deviation of all R–R intervals; RMSSD: the root mean square of successive differences; pNN50: the percentage of successive normal sinus RR intervals more than 50 ms; PNS: Parasympathetic nervous system; SNS: Sympathetic nervous system; HVLA: high-velocity low amplitude technique; LF: low frequency; HF: high frequency.

When considering the time domain, an increase of all the indices (SDNN, RMSSD; pNN50) was found, indicating a PNS effect, independent of the techniques used and the body region where those techniques were applied. For the frequency domain, an increase in LF (without specifying if absolute or normalized values) was shown when applying manipulations to lower cervical and upper thoracic, suggesting an increased SNS activity [44, 47]. HF showed contradictory results depending on the technique and the body regions where the intervention was administered. A decrease in the HF absolute value was found when applying manipulations to the lower neck and upper thoracic [47]. An increase in HF absolute values was observed when manipulation was used to the upper neck [44] and yet an increase of the HF—both absolute values and normalized units—after myofascial techniques. The majority of the included papers assessing the LF/HF ratio found a decrease in this ratio, meaning a parasympathetic effect. This PNS effect was observed for manipulation techniques to the upper neck and lumbar spine and for myofascial techniques [44, 47]. Notwithstanding this PNS response, the LF/HF ratio was found to increase when applying manipulation techniques to the lower neck and upper thoracic spine, indicating an increased SNS response [44, 47]. One SR did not find any effect on HRV values (HF spectral power and LF/HF values) after mobilisations or manipulations [45].

Assessing ANS with other autonomic markers. Eight papers in our review used BP and HR. Three SRs found an increase in systolic blood pressure after manipulation of the neck [47] and after mobilisations [41, 45] and in the diastolic blood pressure after neck manipulations [72]. One SR found a decrease in systolic BP in hypertensive type I subjects but not in healthy participants [71]. Two studies found an increase in HR after mobilisations [49, 67], and one found no effect after cervical manipulation [71]. No effect was also found on BP and HR after either cranial techniques [48] or spinal manipulations [45].

As far as respiratory rate is considered, 3 systematic reviews took it into account as an autonomic marker. One SR argued that RR increases after oscillatory mobilisations even if the overall evidence was very low [45], confirming previous SRs [41, 70].

Concerning oxygen saturation, two articles did not show any effect after manipulations in the neck or upper thoracic area [47, 71].

Three SRs assessed ANS with pupillometry. All of them found no changes in pupil diameter after manipulations compared to placebo [45, 47, 49]. However, one SR found that the pupil diameter decreased when comparing manipulations with no treatment instead of placebo [49].

Plasma catecholamine did not show any effect after manipulations and cranial techniques [45, 48].

Quality assessment tools used in the included reviews

The reviews differed in the approach used to assess the internal validity of the primary studies which they included (“Table 8 and S5 Table”). Only three performed a domain- based assessment [41, 45, 46] and the rest used a variety of scores. For that reason, judgements on bias or quality of overlapping primary studies among the included SRs varied in some cases. Two reviews at low risk of bias that used the Downs and Black scale agreed in the score provided to the two studies included in both reviews [47, 48], but two additional reviews showed discrepancies using the Cochrane risk of bias criteria for some primary studies. Agreements and discrepancies among more than two SRs are shown in “Table 8”.

Table 8. Agreements and discrepancies among reviews [more than 2] rating the same article.

Primary studies Agreement among reviews rating the same article Systematic reviews
Budgell and Hirano (2001) NO Amoroso-Borges 2018, Araujo 2018, Picchiotino 2019, Rechberger 2019
Budgell and Polus (2006) NO Amoroso-Borges 2018, Araujo 2018, Picchiotino 2019, Wirth 2019
Chiu and Wright (1996) NO Schmid 2008, Hegedus 2011, Chu 2014, Kingston 2014, Araujo 2018, Navarro-Santana 2019, Rechberger 2019
Chiu and Wright (1998) NO Schmid 2008, Hegedus 2011, Navarro-Santana 2019
Henderson et al. NO Hegedus 2011, Picchiotino 2019, Rechberger 2019
Jowsey and Perry (2010) NO Hegedus 2011, Chu 2014, Kingston 2014, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019, Rechberger 2019
La Touche et al. (2013) NO Chu 2014, Lascurain 2016, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019, Rechberger 2019
McGuiness et al. (1997) NO Schmid 2008, Kingston 2014, Araujo 2018, Picchiotino 2019
Moulson et al. (2006) NO Hegedus 2011, Chu 2014, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019
Moutzouri et al. (2012) NO Araujo 2018, Navarro-Santana 2019, Picchiotino 2019
Paungmali et al. YES Navarro-Santana 2019, Picchiotino 2019
Perry and Green (2008) NO Hegedus 2011, Kingston 2014, Picchiotino 2019
Perry and Green (2011) YES Araujo 2018, Navarro-Santana 2019
Perry et al. (2011) YES Amoroso-Borges 2018, Araujo 2018
Petersen et al. (1993) NO Schmid 2008, Hegedus 2011, Chu 2014, Kingston 2014, Navarro-Santana 2019, Picchiotino 2019, Rechberger 2019
Piekarz and Perry YES Navarro-Santana 2019, Picchiotino 2019
Puhl et al. (2012) YES Araujo 2018, Picchiotino 2019
Roy et al. (2009) YES Amoroso-Borges 2018, Picchiotino 2019, Rechberger 2019, Wirth 2019
Sillevis et al. (2010) YES Araujo 2018, Picchiotino 2019
Simon YES Navarro-Santana 2019, Picchiotino 2019
Slater et al. (1994) NO Hegedus 2011, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019
Sterling et al. (2001) NO Schmid 2008, Kingston 2014, Lascurain 2016, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019
Tsirakis NO Navarro-Santana 2019, Picchiotino 2019
Vicenzino et al. (1994) NO Schmid 2008, Chu 2014, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019
Vicenzino et al. (1998) a NO Schmid 2008, Kingston 2014, Lascurain 2016, Araujo 2018, Navarro-Santana 2019, Picchiotino 2019
Vicenzino et al. (1998) b NO Schmid 2008, Chu 2014, Picchiotino 2019
Ward et al. NO Galíndez-Ibar 2017, Picchiotino 2019, Wirth 2019
Welch, Boone (2008) YES Amoroso-Borges 2018, Rechberger 2019
Win et al. YES Rechberger 2019, Wirth 2019
Zegarra-Parody YES Navarro-Santana 2019, Picchiotino 2019
Zhang et al. (2006) YES Amoroso-Borges 2018, Rechberger 2019

The generalisation of the evidence

Table 9” summarises the generalisation of the evidence resulting from the discussion of the results from included reviews around a list of pre-specified relevant questions. We responded to these questions weighing up the overall bias from the included reviews (see “Table 4”), their overlapping (see “S4 Table”) and the width of research which were synthetized (“Table 5”).

Table 9. Outline of generalization of the evidence.

GENERALISATION Wirth 2019 * Picchiottino 2019 * Araujo 2018 * Chu 2014 * Navarro-Santana 2019 Hegedus 2011 Rechberger 2019 Galíndez-Ibarbengoetxea 2017 Kingston 2014 Amoroso-Borges 2017 Lascurain 2016 Schmid 2008
Is there evidence of a general autonomic effect of manual therapy interventions across reviews? SNS/PNS SNS SNS SNS SNS SNS ANS NO SNS PNS/SNS SNS SNS
Has this effect a specific ANS direction (i.e. sympathetic, parasympathetic) SNS/PNS SNS (skin) SNS SNS (SC/ST) SNS (SC/ST) SNS (SC) ANS NO SNS (SC/ST) PNS/SNS SNS(SC) SNS (SC)
Is there evidence of the relation between the autonomic effect and the decrease of pain or any other clinical outcome? NO NO NR YES NO YES NR NR YES NR NO NR
Is this effect different when using an isolated MT technique or a combination of different MT techniques/approaches? NR NR NR NR NR NR YES NR NR NR NR NR
Is the effect robust across conditions, type of interventions and age groups? NO NO NO NO NO NO NO NO NO NO NO NO
Is the body region where the technique is applied important to observe any specific effect? YES PNS (cervical and lumbar)/SNS (thoracic) NO NO NO NO NR NO NO NO YES PNS (cervical and lumbar)/ SNS (thoracic) NO YES SNS (Cervical)
Is there evidence for the duration of the autonomic effect? (short, medium or long-term effect) short short short short short short short short short short short short

H: High Risk of Bias in ROBIS assessment; U: Unclear Risk of Bias in ROBIS assessment; L: Low Risk of Bias in ROBIS assessment; SNS: sympathetic Nervous System; PNS: Parasympathetic Nervous System; ANS: Autonomic Nervous System; SC: Skin Conductance; ST: Skin Temperature; NR: Not reported.

*Low Risk of Bias (ROBIS Assessment).

Is there evidence of a general autonomic effect of manual therapy interventions across reviews?

Not all the included reviews assessed the same autonomic marker; therefore, evidence about a general effect of manual therapy interventions is not found among the reviews included. However, depending on the autonomic marker and system, an autonomic effect has been observed after manual therapy interventions.

Has this effect a specific ANS direction (i.e. sympathetic, parasympathetic)?

It seems consistent across reviews an SNS excitation when assessing skin autonomic activity. A PNS excitation seems to occur in cardiovascular autonomic activity, although it has not been mainly studied among included reviews.

Is there evidence of the relation between the autonomic effect and the decrease of pain or any other clinical outcome?

Five reviews included did not report the clinical relevance of the findings. The ones that reported it claimed caution when interpreting the clinical association between ANS effects and clinical outcomes improvement due to their inconclusive results.

Is this ANS effect different when using an isolated MT technique or combining different MT techniques/approaches?

Only one review [48] included studies with a combination of different MT and did not report the clinical relevance of the findings.

Is the ANS effect robust across conditions amongst different types of interventions and age groups?

A consistent effect across conditions and age groups has not been observed due to the reviews’ heterogeneity. However, regarding the type of interventions, the SNS excitation found in skin autonomic activity can be elicited by mobilizations. The PNS activation of cardiovascular autonomic activity seems to be elicited when applying manipulations to the upper neck and lumbar spine and applying myofascial techniques.

Is the body region where the technique is applied important to observe any specific effect?

Some particularities were found among reviews regarding the body region where the manual technique was applied. A correlation between the upper neck and lumbar spine with a PNS activation and between the lower neck and upper thoracic with SNS activation has been consistently observed. However, most reviews with higher methodological quality [43, 45, 46, 49] could not differentiate a specific effect depending on the body region where the technique was applied.

Is there evidence for the duration of the autonomic effect?

(short, medium or long-term effect). No evidence for a medium-term effect (from 1 to 24 weeks) or a long-term effect (more than 24 weeks) exists about the autonomic effect elicited by manual therapy interventions due to a lack of studies.

Do the contextual factors and/or the non-specific effects of MT interventions influence the autonomic effects?

None of the included reviews reported contextual factors and the non-specific effects of MT interventions.

Can we infer that the effect might be observed across conditions that are not included in the current overview?

Until more studies show the effect across different populations and conditions, no other inference can be made.

As planned, we attempted to perform a more thorough quantitative analysis of the included studies. However, the low number of meta-analyses included in the SRs and the high heterogeneity of the data prevented us from formally conducting further advanced analyses, including a meta-analysis of the data.

Discussion

This overview included 12 systematic reviews on the autonomic effects of manual therapy interventions. Although there was a high degree of overlap between reviews, none were excluded to delve deeply into their high degree of heterogeneity.

Overall, the present overview of SRs suggests that MT techniques elicit changes in the ANS. Consistent results were found for a short-term SNS excitation of autonomic skin activity when assessed with SC after spinal mobilisations regardless of the body region treated. A PNS effect is seen when evaluating the ANS with HRV, despite some contradictory findings and that PNS autonomic markers have not been adequately studied in the reviews included in this overview.

Beyond the findings observed in the SRs, four primary areas of discussion emerged from a closer look at the results: 1) the specific effects following MT interventions (that includes the types of techniques and the body region of treatment) and the autonomic markers used to assess these effects; 2) the clinical relevance of the findings 3) the non-specific effects of MT interventions that might influence ANS, and 4) the methodological aspects related to MT research conducted in the field of ANS.

Autonomic specific effects following MT interventions

The current overview shows that the effects elicited by MT on ANS rely mainly on the autonomic marker used. It is important to highlight that peripheral ANS has an extraordinary functional specificity defined according to the effector cells [74]. In this context, a general consistent bodily response is, indeed, improbable, and therefore, general activation or inhibition of the ANS is very unlikely [34, 51, 74, 75]. The following section discusses the different types of techniques, the related specific effects and the body region treated and categorised by the ANS marker used.

Assessing ANS with skin conductance

The reviews using SC reported a consistent acute sympatico-excitation effect independent from the technique used and the body region where the technique was applied.

Skin conductance can quantify the SNS state more reliably because of the sympathetic cholinergic system control on the sudomotor activity [76]. This fact might explain the specific activation of the SNS when assessing with SC. Interestingly, sudomotor activity is independent of haemodynamic variability and respiratory rate and can be affected by skin quality, moisture levels and environmental temperature (see [77] for a comprehensive review). In addition, local physiological variations (e.g. skin temperature) due to touch or prolonged contact with the operator could influence the effects of manual interventions on the SC parameter rather than an increase in sympathetic activity "per se". For this reason, the SC assessment has to be carefully interpreted and especially when comparing between individuals focusing on each patient’s variability.

Assessing ANS with HRV

Reviews using HRV concluded that spinal manipulations, mobilizations, myofascial and cranial techniques could elicit a short-term PNS activation. Body regions seem to influence when spinal manipulations are applied to lower cervical and upper thoracic areas, as one review found an SNS activation [47]. In addition, one SR did not find any effect on HRV after MT interventions [45].

HRV is a reliable marker to assess the autonomic nervous system [5, 6, 8, 7880]. It consists of the change in the time interval between successive heartbeats [5]. It can be measured during 24 hours, short-term (5 minutes) or ultrashort-term (<5 minutes), using time-domain, frequency-domain or non-linear measures [8]. Most of the time-domain indices provide an assessment of vagal tone [81]. For the frequency-domain indices, HF is influenced by PNS activity, whereas the LF is influenced by both sympathetic and parasympathetic components making the method less specific for SNS activity; the ratio LF/HF reflects sympathovagal balance in terms of cardiac modulation [57, 81]. Non-linear measurements are considered sensitive parasympathetic indices [25]. Complex interactions between linear and non-linear measurements are necessary to interpret HRV properly. Indeed, an increased PNS activity may be associated with a decrease, increase, or no change in SNS activity [8]. As shown in the results, most of the articles using HRV measurements combined few HRV metrics, reducing the possibility of understanding the ANS reaction fully.

Two recent randomized clinical trials combined linear with non-linear metrics in the HRV measurement of different manual interventions confirming the probable PNS activation [25, 82, 83]. Furthermore, only one review [44] correlated the time with frequency domain indices and no one correlated linear with non-linear metrics. A recent SR aiming to investigate whether HRV parameters are altered in people with chronic low back pain compared to healthy controls suggested that it may be probable that chronic low back pain patients presented a lower vagal activity evidenced by HRV [53].

On the contrary, data obtained with parameters such as LF and LF / HF are not very specific and are not always an index of the autonomic balance [5, 8, 80]. When comparing frequency values as LF and HF among the studies, conclusions can not be accurate if values are not compared in the same units (absolute or normalized) because their interpretation might differ [81].

Besides, any review included long-term HRV measurement, representing the gold standard for clinical HRV assessment [8]. Moreover, Laborde et al. proposed the 3R of HRV (resting, reactivity and recovery), measuring HRV at three points: baseline, event and post-event. Therefore, accurate analysis of HRV is necessary to estimate more precise and reliable results [4, 5, 8, 74, 76].

Assessing ANS with other markers

Other markers used to measure the effects on ANS were ST, SBF, RR, HR, BP, pupillometry and plasma catecholamines. When assessing SBF and ST, contradictory results were found. A decrease of ST (without specifying where the ST was measured) was found after mobilisations of different body regions in most of the SRs unless for Picchiottino et al. reporting no effect [45]. Indeed, both an SNS activation and a PNS activation has been shown.

Interestingly, Zegarra-Parodi et al. pointed out that non-sympathetic factors are also involved in SBF and ST regulation (e.g. local response of vascular endothelial cells to metabolites and environmental and humoral stimuli), questioning, therefore, the appropriateness of such markers assessing the sympathetic cholinergic system [42, 84]. Indeed, its interpretation could be more accurate when correlating the results with other autonomic markers. The gold-standard method for measuring sympathetic activity is through direct intraneural measures using microneurography, although other rigorous methods, including norepinephrine spillover techniques, can be successfully employed [85].

In our overview, several articles [41, 45, 4749, 7072] assessed ANS activity with BP and HR, and contradictory results were also found among the studies. A decrease in BP was found after cranial techniques and an increase after spinal manipulations to the upper neck. In addition, no effect was found after spinal mobilizations. Many mechanisms can influence BP, depending on which factor is driving the blood pressure response. An increase in blood pressure can affect the modulation of autonomic outflow via the baroreflex [80, 86]. Thus, only cautious interpretations can be made. It is worth noting that blood pressure, heart rate, and respiration are the primary physiological parameters that could be recorded during autonomic tests, from which heart rate variability and blood pressure variability, among other autonomic parameters, are calculated. Therefore, they must be considered to contribute equally and to have the same importance when measuring, assessing and interpreting the overall autonomic response [6, 78, 79, 87].

Surprisingly, only a few reviews reported the RR assessment, concluding an increase after mobilisations. The assessment of RR is fundamental when exploring ANS on the cardiovascular system because it influences on HR [79, 87]. However, RR can be affected by age, resting heart rate, body mass index and pharmacological assumptions [6].

Three SRs [45, 47, 49] included primary articles assessing ANS through pupil diameter but did not find any effect after MT interventions. Interestingly, Araujo et al. noted a different response of the pupil diameter when comparing the intervention with a placebo instead of no intervention, suggesting a potential non-specific effect of placebo on ANS [49]. The use of pupillometry to assess MT interventions effects is rare compared to other ANS markers. As pointed out by some authors, it is not easy to interpret that it requires specialised expertise and skilled specialists are needed to perform it correctly [79].

The SRs using plasma catecholamines to assess ANS activity found no effect when applying cranial techniques and spinal manipulations [45, 48]. Plasma catecholamines is a biochemical indicator of the sympathetic adrenergic system (dopamine, adrenaline, noradrenaline) but have some limitations: noradrenaline is subject to reuptake, its proportion circulating is very small related to all the amount of neurotransmitters secreted from nerve terminals, and it does not allow an assessment of PNS or sympathetic cholinergic system because plasma acetylcholine is highly labile and quickly decomposed preventing quantification [6, 7, 76]. Therefore, it should be used in combination with other autonomic markers to strengthen the interpretation of the results [7].

Autonomic markers: the need for simultaneous multiple autonomic measurements

The methods used to assess the ANS differ among the reviews included. The most common markers were HRV and SC, as confirmed by the ANS literature [79]. Although several indices are recommended to study the ANS response more in-depth [45, 80, 87], most articles assessed the ANS partially. Because of the complexity of the autonomic system, it has been argued that no single test can show a high level of accuracy for specific elements and functions of the ANS [6, 7, 76, 80]. Indeed, the combination of complementary measures, such as HRV and SC as well as variations on BP [87] and HR during head-up tilt test, Valsalva manoeuvre and deep breathing [76], is essential to cover the different ways in which the ANS responds to external stimuli and to obtain a more precise and realistic picture of the ANS function [25, 76]. Also, the Autonomic Reflex Screen is recommended to test cardiovagal, sudomotor and adrenergic functions of the ANS in a standardized fashion way [80]. Therefore, the reduced use of simultaneous multiple autonomic measurements might limit the quality of the results.

In addition to taking more than one measure, it is necessary to consider that the information given by those markers can be influenced by several physiological and psychological conditions [5, 30, 75, 78]. Stable variables (i.e. age, sex, toxic habits, medication) and transient variables (routines as sleeping, physical activity and meals) should be routinely collected while conducting ANS research to guarantee validity and reproducibility [6, 7, 79]. None of our included reviews reported baseline variables of the participants they included.

Clinical relevance of the autonomic effects elicited by MT interventions

Even if most of the reviews included reported data about symptomatic and asymptomatic populations, many of the studies included in the reviews were conducted on healthy patients. So, the translation into a real clinical-based practice setting should be done with caution. Moreover, most of the articles reviewed assessed only short-term effects, and very few used additional PROMs to correlate with ANS changes. These elements raise doubts about the clinical relevance of these results: an argument also initially discussed by Picchiottino et al. and Wirth et al. [45, 47].

In clinical practice, most patients seeking manual interventions have chronic diseases [1618, 88]. Up to now, scientific literature has described only the short-term effects of MT [63], so exploring the sustained effects through sessions is crucial. Nevertheless, it has been argued that short-term effects might not have a predictive value over time [25], implying the need for assessing both short- and long-term effects [50].

Initial evidence showed contradictory results for SC and pupillometry studies correlating ANS indices scores with pain values [78, 89]. Indeed, Lascurain-Aguirrebeña et al. did not find any correlation between sympathetic-excitatory changes and neck pain relief [90]. Notwithstanding this, Carnevali and colleagues reported preliminary evidence of the beneficial effects of MT in three pilot studies conducted on pathological (e.g. hypertension) and physiological conditions (e.g. recovering from sports competition) [50]. Therefore investigating the impact of MT on the autonomic indices enrolling patients with pain or other clinical conditions, including dysautonomic syndromes, is paramount.

Non-specific ANS effects after manual therapy interventions

A relevant point to consider when assessing ANS after MT interventions are the number and type of control groups, namely the effect of placebo response in ANS studies. The placebo/sham effect (caused by expectation and learning) affect on the central nervous system eliciting a hypoalgesic reaction by modulating the autonomic response [9193]. Interestingly, Navarro-Santana and colleagues argued that the effect size of real treatment, e.g. SC and ST, is reduced from large to moderate when joint mobilisations were compared to a placebo group rather than a hands-off control group [46]. Furthermore, Araujo et al. found that the pupil diameter did not change after manipulations compared to placebo but decreased compared to no-treatment [49]. These results endorse the fact that placebo/sham can elicit neuropsychological effects (i.e. conditioning or expectation), modifying the body-brain interactions through ANS, among other systems. For a comprehensive review, see [9197]. Three-quarters of the articles included in this review were sham-controlled clinical trials; however, different placebo/shams were used as a control group. This fact implies high methodological heterogeneity among studies in terms of the type of placebo used that might, in part, explain the inconclusive and contradictory results found in our review.

Moreover, contextual factors (during therapeutic encounters between patients and health providers) in manual therapy interventions are crucial to consider because of the influence on ANS [98]. These factors can modify the autonomic response and might modulate pain experience [98]. Also, the emotional/cognitive state of the subject is important to take into account as it can affect autonomic responses [99].

The use of appropriate, adequate methodological protocols is even more relevant if the interpretability, robustness and validity of the results are taken into account: indeed, this is linked to the type of control groups used in the studies, the associated clinical measures utilised, and the type of population enrolled. Some authors have already shed light on the inconsistency of results when clinical conditions (i.e. pain) are considered. [30, 77, 78].

Quality of the evidence and methodological considerations of ANS research on MT interventions

The quality of the included review was assessed by the ROBIS tool. This tool is highly recommended when performing overviews or clinical guidelines [65].

We have provided a detailed, transparent assessment of the quality of included reviews describing the rationale related to the ROBIS questions (“S4 Table”). The difference between those with low risk of bias and those with unclear risk of bias was due to the poor reporting of information, lack of protocol registration and methodological deficiencies (poor data analysis and reporting of the data, limited answer to the research question, absence of reporting search strategy).

Different methods to assess the quality or the risk of bias have been used within the included SRs. We observed discrepancies in the judgement to some studies included in several reviews; in part for the different approaches to this construct by the different scales and domain-based approaches, but also related to other factors such as a variance due to learning curve or the knowledge of these tools. The quality of RCTs is a persistent issue in the field of MT. Several studies have shown a low quality of RCTs performed in MT [11, 100, 101]. Our overview identified a high heterogeneity in regards to the quality of the articles included. Moreover, recent studies investigating disagreements on rating the quality of RCTs included in more than one SR showed that the scores differed substantially where different reviews rate the same article differently [102, 103]. Another reason that leads to heterogeneity relates to the incomplete or unclear reporting, as also noted by Alvarez et al. [11]. Consistent with the literature, the studies included in the present overview revealed the same issues, such as high heterogeneity, reporting deficiencies and the same articles rated differently.

Results from recent RCT’s

Few RCTs have been recently published that were not included in the reviews included in this overview.

Cerritelli et al. aimed to study the ANS effects after osteopathic manipulative treatment. They combined different autonomic markers to assess the autonomic response of MT interventions concluding a PNS activation in the cardiovascular assessment and the thermal skin response and an SNS activation in skin conductance [25]. In addition, these effects were maintained at medium-term. This PNS activation on cardiovascular assessment was confirmed by four other studies [82, 83, 104, 105]. All of them include different types of techniques applied in different body regions.

Suggestions and recommendations for further research

Basic research has evolved our knowledge concerning ANS function. However, daily care is a complex environment, where the complexity of the patients requires complex multidimensional interventions. This complex scenario pushes science to extend the research from bench to bedside to enactivism [106108]. In that sense, designing RCTs comparing an intervention with placebo and no treatment, or assessing ANS markers in patients and correlating the results with patients benefits, in a more ecological environment, could fill the gap of clinical transferability [109]. In terms of design, different methodological solutions have been proposed recently to adapt RCTs for complex interventions like MT. For example, realistic RCTs aim to assess the effects and the mechanisms behind this effect and even how these mechanisms interact with the context [110]. Pragmatic RCTs and comparative effectiveness of N-of-1 trials could also be suitable alternatives [111, 112], especially when the high variability among individuals is an issue, and thus the solution is to focus on individual variability [77].

According to our results, we argue that several points should be taken into account when performing research exploring the autonomic effects of MT interventions (“Table 10”).

Table 10. Suggestions and recommendations for further research in the field of autonomic nervous system.

Topic Current issue Proposed solution Expected impact Example in manual research
Autonomic markers Use of a single marker Contextual use of multiple autonomic methods Broaden the study of the ANS function Use of the following methods: HRV, SC, thermography, BP and RR
Autonomic assessment Uncertain relevance of the results Broaden the assessment to complement the ANS markers Correlate physiological outcomes with clinical relevance Use of PROMs, anamnesis and physical examination
Confounding factors Heterogeneity of the results and lack of replicability Standardise the variables that can influence the ANS assessment Replicability of the studies and methodological homogeneity  See example guidelines Laborde et al. and Zygmunt et al.
Population Research mostly in healthy subjects Include specific population and comorbidities Increase clinical relevance Include patients with chronic pain
Follow-up Short-term effects of MT Include longer time points Long-term effects of MT measures at 5, 15, 30, 60, 120 min after the MT
Quality of the studies Poor reporting  Use of design and reporting tools  Increase of the quality Use of Tidier, Consort, Precis
Study design Doubtful applicability of the results New approaches and study designs Clinical relevance and applicability of results Realistic RCT

ANS: Autonomic Nervous system; HRV: heart rate variability, SC: skin conductance; BP: blood pressure; RR: respiratory rate; PROMs: patient reported outcomes; MT: manual therapy; RCT: randomized clinical trials.

First, to reach a robust conclusion on the effects of a given MT intervention, several autonomic markers (assessing different body domains) should be considered in the study design. Combining various measures is recommended to obtain a clear picture of ANS activity [7, 25, 45, 87, 113]. For example, a combination of HRV, SC, thermography, BP and RR could improve the assessment of ANS. Moreover, complementary assessments using PROMs about autonomic symptoms could help evaluate the relevance of the results offered by the autonomic markers [77]. Outcomes should be able to relate ANS changes with therapeutic benefits.

Although the research on healthy subjects could bring preliminary results, studies including specific populations (e.g. chronic pain patients) would increase the clinical relevance. Additionally, correlating the results with the anamnesis and the physical examination might increase the pertinence of the physiological outcomes. In addition, controlling for confounding factors is essential: for example, caffeine and nicotine should be abstained from at least 3 hours before testing, no physical training the day before, no meal 2 hours before the intervention, no alcohol for 24 hours before the measurement and where possible drugs affecting ANS should be avoided at least 48 hours before the study begins. Moreover, the patient should use the bathroom before the intervention and be laid down or seated for about 30 minutes in a quiet room with a neutral temperature and humidity [5, 6].

Regarding the research design and reporting, MT studies on the ANS field should consider several points: long-term autonomic effects of MT interventions have to be explored. The use of standardised intervention reporting guidelines should be thoroughly recommended to improve study quality [102, 103, 114]. Also, articles should describe interventions more appropriately to adequately understand the techniques used in the studies, even if a patient-based approach is applied. Finally, new designs and experimental approaches can be considered in the complex scenario of MT.

Key messages

  • Research suggests that MT can produce both a PNS and an SNS short-term effect depending on the ANS measurement method.

  • Skin conductance and heart rate variability are the most frequent autonomic measures to assess ANS. However, there is the need for a combination of measures to have a clearer and a more robust conclusion about the effect of MT interventions on ANS

  • There is no evidence of the association of specific manual techniques with precise autonomic responses

  • There is still lack of robust evidence in regards to the body regions where the technique is applied and specificity of the autonomic effects

  • Based on all current evidence, it is difficult to conclude whether the findings on the autonomic effects produce any clinically relevant results in these studies

Potential biases in the overview process, strengths and limitations

None of the authors of this overview was involved in any of the reviews included in the primary studies. We used an unambiguous definition of systematic reviews [57] to establish eligibility criteria and ensure the inclusion of studies conducted rigorously and that could identify the breadth of evidence informing the clinical question. To identify the completeness of existing reviews we planned a search strategy adhering current guidance [115]. We aimed to obtain a scoping picture from the reviews addressing the potential autonomic effects of manual therapies resulting in broad eligibility criteria to include in a first step review irrespective of their publication date or quality. Current guidance to conduct overviews does not reach a consensus to recommend an approach to assess the risk of bias from systematic reviews when conducting an overview [54, 55]. Although AMSTAR and ROBIS have shown similar reliability and performance [116, 117] we made the decision to use ROBIS as it allows a domain-focused appraisal. The decision to include any identified reviews, data extraction and methodological quality assessment of the included reviews was based on an independent assessment by two overview authors (SR, GA) with discussion involving a third overview author (FC) when a disagreement arose.

Although we recognise that potential biases exist at all stages of the overview process, efforts have been made to reduce them throughout the process, especially in the generalisation of the evidence, where no validated tool has been used. Some of these biases were inherent to the characteristics of included reviews but we established mechanisms to address them analysing the overlap between reviews and with a formal assessment of their bias, allowing us to interpret their findings accordingly. Also, the recency of some reviews [41, 43, 72, 73] could be a source of concern, but we formally assessed their up-to-dateness [118] and interpreted their results in consequence. It would be informative to have included judgements on the certainty of our findings, but at present formal guidance on how to use GRADE in conducting overviews is still pending [54].

Implications for research

According to all the issues discussed above, our findings have some implications for research and allow suggesting specific recommendations in order to improve both the quality and clinical relevance of future studies in this field. Future studies should be designed with pragmatic approach and promote the inclusion of individuals with specific conditions. The impact of manual therapies should be assessed using a variety of standardised autonomic markers in order to cover the entire range of potential ANS effects. Also, the studies should improve their design and execution considering patient-centred approaches, selecting control conditions carefully, anticipating the effect of confounding and planning a follow up at long term. Finally, a complete, accurate and transparent report of all the studies conducted should be ensured.

Conclusions

The findings of this overview of systematic reviews showed that manual therapies may have an effect on both sympathetic and parasympathetic systems. However, the systematic reviews included showed inconsistent results, largely explained by differences in their methodological rigour and how the effects were measured. The majority of reviews with a lower risk of bias could not discriminate the effects depending on the body region to which the technique was applied. In consequence, the magnitude of the specific autonomic effect elicited by manual therapies and its clinical relevance is uncertain.

Supporting information

S1 Checklist

(PDF)

S1 Table. Search strategy.

(DOCX)

S2 Table. Data extraction form.

(XLSX)

S3 Table. Risk of bias of included reviews (complete ROBIS assessments).

(DOCX)

S4 Table. Concordance overlapping and conclusions.

(DOCX)

S5 Table. Agreements and discrepancies.

(DOCX)

Acknowledgments

We would like to thank Andy Otaqui, Luca Carnevali and Prof. Andrea Sgoifo for their help in reviewing the paper.

Abbreviations

ANS

Autonomic Nervous System

SNS

Sympathetic Nervous System

PNS

Parasympathetic Nervous System

MT

Manual Therapy

SR

Systematic Review

PROMs

Patient-Reported Outcomes

RCT

Randomized clinical trial

SC

Skin Conductance

ST

Skin Temperature

BP

Blood pressure

HR

Heart rate

HRV

heart rate variability

RR

Respiratory Rate

PC

Plasma Catecholamine

SBF

Skin Blood Flow

LF

Low Frequency

HF

High Frequency

RoB

Risk of bias

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

Funding for the publication of this article was provided by Registro de Osteopatas de España (ROE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Langley JN. The autonomic nervous system [Pt. I]. 1921. Available from: https://psycnet.apa.org/record/1923-10293-000 [Google Scholar]
  • 2.Cannon WB. ORGANIZATION FOR PHYSIOLOGICAL HOMEOSTASIS. Physiol Rev. 1929; 19:399–431. doi: 10.1152/physrev.1929.9.3.399 [DOI] [Google Scholar]
  • 3.Goldstein DS. Differential responses of components of the autonomic nervous system. Handb Clin Neurol. 2013;117:13–22. doi: 10.1016/B978-0-444-53491-0.00002-X . [DOI] [PubMed] [Google Scholar]
  • 4.Freeman R, Chapleau MW. Testing the autonomic nervous system. Handb Clin Neurol. 2013;115:115–36. doi: 10.1016/B978-0-444-52902-2.00007-2 . [DOI] [PubMed] [Google Scholar]
  • 5.Laborde S, Mosley E, Thayer JF. Heart Rate Variability and Cardiac Vagal Tone in Psychophysiological Research—Recommendations for Experiment Planning, Data Analysis, and Data Reporting. Front Psychol. 2017;8:213. doi: 10.3389/fpsyg.2017.00213 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zygmunt A, Stanczyk J. Methods of evaluation of autonomic nervous system function. Arch Med Sci. 2010;6:11–8. doi: 10.5114/aoms.2010.13500 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dobrek Ł, Thor P. Current concepts in clinical and laboratory assessments of autonomic nervous system activity. J Pre Clin Clin Res. 2015;9:63–8. doi: 10.5604/18982395.1157579 [DOI] [Google Scholar]
  • 8.Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017;5:258. doi: 10.3389/fpubh.2017.00258 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chiera M, Cerritelli F, Casini A, Barsotti N, Boschiero D, Cavigioli F, et al. Heart Rate Variability in the Perinatal Period: A Critical and Conceptual Review. Front Neurosci. 2020;14:561186. doi: 10.3389/fnins.2020.561186 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Clar C, Tsertsvadze A, Court R, Hundt GL, Clarke A, Sutcliffe P. Clinical effectiveness of manual therapy for the management of musculoskeletal and non-musculoskeletal conditions: systematic review and update of UK evidence report. Chiropr Man Therap. 2014;22:12. doi: 10.1186/2045-709X-22-12 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Alvarez G, Solà I, Sitjà-Rabert M, Fort-Vanmeerhaeghe A, Gich I, Fernández C, Bonfill X, et al. A methodological review revealed that reporting of trials in manual therapy has not improved over time. J Clin Epidemiol. 2020;121:32–44. doi: 10.1016/j.jclinepi.2020.01.006 . [DOI] [PubMed] [Google Scholar]
  • 12.Bishop MD, Torres-Cueco R, Gay CW, Lluch-Girbés E, Beneciuk JM, Bialosky JE. What effect can manual therapy have on a patient’s pain experience? Pain Manag. 2015;5:455–64. doi: 10.2217/pmt.15.39 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Alvarez G, Núñez-Cortés R, Solà I, Sitjà-Rabert M, Fort-Vanmeerhaeghe A, Fernández C, et al. Sample size, study length, and inadequate controls were the most common self-acknowledged limitations in manual therapy trials: A methodological review. J Clin Epidemiol. 2021;130:96–106. doi: 10.1016/j.jclinepi.2020.10.018 . [DOI] [PubMed] [Google Scholar]
  • 14.Fawkes CA, Leach CM, Mathias S, Moore AP. A profile of osteopathic care in private practices in the United Kingdom: a national pilot using standardised data collection. Man Ther. 2014;19:125–30. doi: 10.1016/j.math.2013.09.001 . [DOI] [PubMed] [Google Scholar]
  • 15.van Dun PLS, Nicolaie MA, Van Messem A. State of affairs of osteopathy in the Benelux: Benelux Osteosurvey 2013. Int J Osteopath Med. 2016;20: 3–17. doi: 10.1016/j.ijosm.2016.01.003 [DOI] [Google Scholar]
  • 16.Alvarez G, Roura S, Cerritelli F, Esteves JE, Verbeeck J, van Dun PLS. The Spanish Osteopathic Practitioners Estimates and RAtes (OPERA) study: A cross-sectional survey. PLoS One. 2020;15(6):e0234713. doi: 10.1371/journal.pone.0234713 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cerritelli F, van Dun PLS, Esteves JE, Consorti G, Sciomachen P, Lacorte E, et al. ; OPERA-IT Group. The Italian Osteopathic Practitioners Estimates and RAtes (OPERA) study: A cross sectional survey. PLoS One. 2019;14:e0211353. doi: 10.1371/journal.pone.0211353 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cerritelli F, Consorti G, van Dun PLS, Esteves JE, Sciomachen P, Lacorte E, et al. ; OPERA-IT Group. The Italian Osteopathic Practitioners Estimates and RAtes (OPERA) study: How osteopaths work. PLoS One. 2020;15:e0235539. doi: 10.1371/journal.pone.0235539 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Franke H, Franke J-D, Fryer G. Osteopathic manipulative treatment for chronic nonspecific neck pain: A systematic review and meta-analysis. Int J Osteopath Med. 2015;18: 255–67. doi: 10.1016/j.ijosm.2015.05.003 [DOI] [Google Scholar]
  • 20.Franke H, Franke JD, Belz S, Fryer G. Osteopathic manipulative treatment for low back and pelvic girdle pain during and after pregnancy: A systematic review and meta-analysis. J Bodyw Mov Ther. 2017;21:752–762. doi: 10.1016/j.jbmt.2017.05.014 . [DOI] [PubMed] [Google Scholar]
  • 21.Dal Farra F, Risio RG, Vismara L, Bergna A. Effectiveness of osteopathic interventions in chronic non-specific low back pain: A systematic review and meta-analysis. Complement Ther Med. 2021;56:102616. doi: 10.1016/j.ctim.2020.102616 . [DOI] [PubMed] [Google Scholar]
  • 22.Voogt L, de Vries J, Meeus M, Struyf F, Meuffels D, Nijs J. Analgesic effects of manual therapy in patients with musculoskeletal pain: a systematic review. Man Ther. 2015;20:250–6. doi: 10.1016/j.math.2014.09.001 . [DOI] [PubMed] [Google Scholar]
  • 23.Licciardone JC, Gatchel RJ, Aryal S. Recovery From Chronic Low Back Pain After Osteopathic Manipulative Treatment: A Randomized Controlled Trial. J Am Osteopath Assoc. 2016;116:144–55. doi: 10.7556/jaoa.2016.031 . [DOI] [PubMed] [Google Scholar]
  • 24.Cerritelli F, Lacorte E, Ruffini N, Vanacore N. Osteopathy for primary headache patients: a systematic review. J Pain Res. 2017. Mar;10:601–611. doi: 10.2147/JPR.S130501 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cerritelli F, Cardone D, Pirino A, Merla A, Scoppa F. Does Osteopathic Manipulative Treatment Induce Autonomic Changes in Healthy Participants? A Thermal Imaging Study. Front Neurosci. 2020;14:887. doi: 10.3389/fnins.2020.00887 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bronfort G, Haas M, Evans R, Leininger B, Triano J. Effectiveness of manual therapies: the UK evidence report. Chiropr Osteopat. 2010;18:3. doi: 10.1186/1746-1340-18-3 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bokarius AV, Bokarius V. Evidence-based review of manual therapy efficacy in treatment of chronic musculoskeletal pain. Pain Pract. 2010;10:451–8. doi: 10.1111/j.1533-2500.2010.00377.x . [DOI] [PubMed] [Google Scholar]
  • 28.Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther. 2009;14:531–8. doi: 10.1016/j.math.2008.09.001 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bialosky JE, Beneciuk JM, Bishop MD, Coronado RA, Penza CW, Simon CB, et al. Unraveling the Mechanisms of Manual Therapy: Modeling an Approach. J Orthop Sports Phys Ther. 2018;48:8–18. doi: 10.2519/jospt.2018.7476 . [DOI] [PubMed] [Google Scholar]
  • 30.Gyer G, Michael J, Inklebarger J, Tedla JS. Spinal manipulation therapy: Is it all about the brain? A current review of the neurophysiological effects of manipulation. J Integr Med. 2019;17:328–337. doi: 10.1016/j.joim.2019.05.004 . [DOI] [PubMed] [Google Scholar]
  • 31.Teodorczyk-Injeyan JA, Injeyan HS, Ruegg R. Spinal manipulative therapy reduces inflammatory cytokines but not substance P production in normal subjects. J Manipulative Physiol Ther. 2006;29:14–21. doi: 10.1016/j.jmpt.2005.10.002 . [DOI] [PubMed] [Google Scholar]
  • 32.Degenhardt BF, Darmani NA, Johnson JC, Towns LC, Rhodes DC, Trinh C, et al. Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. J Am Osteopath Assoc. 2007;107:387–400. . [PubMed] [Google Scholar]
  • 33.Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol. 2003;13:500–5. doi: 10.1016/s0959-4388(03)00090-4 . [DOI] [PubMed] [Google Scholar]
  • 34.King HH, Jänig W, Patterson MM, editors. The Science and Clinical Application of Manual Therapy. 1st ed. Amsterdam: Elsevier; 2010. doi: 10.1016/j.math.2009.12.001 [DOI] [Google Scholar]
  • 35.McGlone F, Cerritelli F, Walker S, Esteves J. The role of gentle touch in perinatal osteopathic manual therapy. Neurosci Biobehav Rev. 2017;72:1–9. doi: 10.1016/j.neubiorev.2016.11.009 . [DOI] [PubMed] [Google Scholar]
  • 36.McGlone F, Wessberg J, Olausson H. Discriminative and affective touch: sensing and feeling. Neuron. 2014;82:737–55. doi: 10.1016/j.neuron.2014.05.001 . [DOI] [PubMed] [Google Scholar]
  • 37.D’Alessandro G, Cerritelli F, Cortelli P. Sensitization and Interoception as Key Neurological Concepts in Osteopathy and Other Manual Medicines. Front Neurosci. 2016;10:100. doi: 10.3389/fnins.2016.00100 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Cerritelli F, Pizzolorusso G, Renzetti C, Cozzolino V, D’Orazio M, Lupacchini M, et al. A multicenter, randomized, controlled trial of osteopathic manipulative treatment on preterms. PLoS One. 2015;10:e0127370. doi: 10.1371/journal.pone.0127370 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Cerritelli F, Chiacchiaretta P, Gambi F, Perrucci MG, Barassi G, Visciano C, et al. Effect of manual approaches with osteopathic modality on brain correlates of interoception: an fMRI study. Sci Rep. 2020;10(1):3214. doi: 10.1038/s41598-020-60253-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Craig AD. An interoceptive neuroanatomical perspective on feelings, energy, and effort. Behav Brain Sci. 2013;36:685–6; discussion 707–26. doi: 10.1017/S0140525X13001489 . [DOI] [PubMed] [Google Scholar]
  • 41.Kingston L, Claydon L, Tumilty S. The effects of spinal mobilizations on the sympathetic nervous system: a systematic review. Man Ther. 2014;19:281–7. doi: 10.1016/j.math.2014.04.004 . [DOI] [PubMed] [Google Scholar]
  • 42.Zegarra-Parodi R, Park PY, Heath DM, Makin IR, Degenhardt BF, Roustit M. Assessment of skin blood flow following spinal manual therapy: a systematic review. Man Ther. 2015;20:228–49. doi: 10.1016/j.math.2014.08.011 . [DOI] [PubMed] [Google Scholar]
  • 43.Chu J, Allen DD, Pawlowsky S, Smoot B. Peripheral response to cervical or thoracic spinal manual therapy: an evidence-based review with meta analysis. J Man Manip Ther. 2014;22:220–9. doi: 10.1179/2042618613Y.0000000062 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Amoroso Borges BL, Bortolazzo GL, Neto HP. Effects of spinal manipulation and myofascial techniques on heart rate variability: A systematic review. J Bodyw Mov Ther. 2018;22:203–208. doi: 10.1016/j.jbmt.2017.09.025 . [DOI] [PubMed] [Google Scholar]
  • 45.Picchiottino M, Leboeuf-Yde C, Gagey O, Hallman DM. The acute effects of joint manipulative techniques on markers of autonomic nervous system activity: a systematic review and meta-analysis of randomized sham-controlled trials. Chiropr Man Therap. 2019;27:17. doi: 10.1186/s12998-019-0235-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Navarro-Santana MJ, Gómez-Chiguano GF, Somkereki MD, Fernández-de-Las-Peñas C, Cleland JA, Plaza-Manzano G. Effects of joint mobilisation on clinical manifestations of sympathetic nervous system activity: a systematic review and meta-analysis. Physiotherapy. 2020;107:118–132. doi: 10.1016/j.physio.2019.07.001 . [DOI] [PubMed] [Google Scholar]
  • 47.Wirth B, Gassner A, de Bruin ED, Axén I, Swanenburg J, Humphreys BK, et al. Neurophysiological Effects of High Velocity and Low Amplitude Spinal Manipulation in Symptomatic and Asymptomatic Humans: A Systematic Literature Review. Spine (Phila Pa 1976). 2019;44:E914–E926. doi: 10.1097/BRS.0000000000003013 . [DOI] [PubMed] [Google Scholar]
  • 48.Rechberger V, Biberschick M, Porthun J. Effectiveness of an osteopathic treatment on the autonomic nervous system: a systematic review of the literature. Eur J Med Res. 2019;24:36. doi: 10.1186/s40001-019-0394-5 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Araujo FX, Ferreira GE, Angellos RF, Stieven FF, Plentz RDM, Silva MF. Autonomic Effects of Spinal Manipulative Therapy: Systematic Review of Randomized Controlled Trials. J Manipulative Physiol Ther. 2019;42:623–634. doi: 10.1016/j.jmpt.2018.12.005 . [DOI] [PubMed] [Google Scholar]
  • 50.Carnevali L, Lombardi L, Fornari M, Sgoifo A. Exploring the Effects of Osteopathic Manipulative Treatment on Autonomic Function Through the Lens of Heart Rate Variability. Front Neurosci. 2020;14:579365. doi: 10.3389/fnins.2020.579365 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Buijs RM. The autonomic nervous system: a balancing act. Handb Clin Neurol. 2013;117:1–11. doi: 10.1016/B978-0-444-53491-0.00001-8 . [DOI] [PubMed] [Google Scholar]
  • 52.Sgoifo A, Carnevali L, Alfonso Mde L, Amore M. Autonomic dysfunction and heart rate variability in depression. Stress. 2015;18:343–52. doi: 10.3109/10253890.2015.1045868 . [DOI] [PubMed] [Google Scholar]
  • 53.Bandeira PM, Reis FJJ, Sequeira VCC, Chaves ACS, Fernandes O, Arruda-Sanchez T. Heart rate variability in patients with low back pain: a systematic review. Scand J Pain. 2021;21:426–433. doi: 10.1515/sjpain-2021-0006 . [DOI] [PubMed] [Google Scholar]
  • 54.Gates M, Gates A, Guitard S, Pollock M, Hartling L. Guidance for overviews of reviews continues to accumulate, but important challenges remain: a scoping review. Syst Rev. 2020;9:254. doi: 10.1186/s13643-020-01509-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Pollock M, Fernandes RM, Becker LA, Pieper D, Hartling L. Chapter V: Overviews of Reviews. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook. [Google Scholar]
  • 56.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Krnic Martinic M, Pieper D, Glatt A, Puljak L. Definition of a systematic review used in overviews of systematic reviews, meta-epidemiological studies and textbooks. BMC Med Res Methodol. 2019;19:203. doi: 10.1186/s12874-019-0855-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook. [Google Scholar]
  • 59.Savoie I, Helmer D, Green CJ, Kazanjian A. Beyond Medline: reducing bias through extended systematic review search. Int J Technol Assess Health Care. 2003;19:168–78. doi: 10.1017/s0266462303000163 . [DOI] [PubMed] [Google Scholar]
  • 60.The American Association of Colleges of Osteopathic Medicine (ACOM). Glossary of Osteopathic Terminology, Prepared by the Educational Council on Osteopathic Principles (ECOP) of the American Association of Colleges of Osteopathic Medicine. Bethesda (MD): The Association; 2017. 84 p. [Google Scholar]
  • 61.Engel RM, Gonski P, Beath K, Vemulpad S. Medium term effects of including manual therapy in a pulmonary rehabilitation program for chronic obstructive pulmonary disease (COPD): a randomized controlled pilot trial. J Man Manip Ther. 2016;24:80–9. doi: 10.1179/2042618614Y.0000000074 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Oliveira-Campelo NM, de Melo CA, Alburquerque-Sendín F, Machado JP. Short- and medium-term effects of manual therapy on cervical active range of motion and pressure pain sensitivity in latent myofascial pain of the upper trapezius muscle: a randomized controlled trial. J Manipulative Physiol Ther. 2013;36:300–9. doi: 10.1016/j.jmpt.2013.04.008 . [DOI] [PubMed] [Google Scholar]
  • 63.Cook C. Immediate effects from manual therapy: much ado about nothing? J Man Manip Ther. 2011;19:3–4. doi: 10.1179/106698110X12804993427009 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Pérez-Bracchiglione J, Niño de Guzmán E, Roqué Figuls M, Urrútia G. Graphical representation of overlap degree of primary studies in systematic reviews included in overviews (OS29.1). 26th Cochrane Colloquium Santiago 2019. [cited 2021 October]. Available from: https://colloquium2019.cochrane.org/. [Google Scholar]
  • 65.Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ; ROBIS group. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34. doi: 10.1016/j.jclinepi.2015.06.005 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Sullivan SG, Paolacci S, Kiani AK, Bertelli M. Chiropractic care for hypertension: Review of the literature and study of biological and genetic bases. Acta Biomed. 2020;91:e2020017. doi: 10.23750/abm.v91i13-S.10524 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Moyer CA, Seefeldt L, Mann ES, Jackley LM. Does massage therapy reduce cortisol? A comprehensive quantitative review. J Bodyw Mov Ther. 2011;15:3–14. doi: 10.1016/j.jbmt.2010.06.001 . [DOI] [PubMed] [Google Scholar]
  • 68.Meyer AL, Amorim MA, Schubert M, Schweinhardt P, Leboeuf-Yde C. Unravelling functional neurology: does spinal manipulation have an effect on the brain?—a systematic literature review. Chiropr Man Therap. 2019;27:60. doi: 10.1186/s12998-019-0265-8 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Bernier Carney KM, Young EE, Guite JW, Starkweather AR. A Systematic Review of Biological Mechanisms and Chronic Pain Outcomes During Stress Reduction Interventions. Biol Res Nurs. 2020;22:205–216. doi: 10.1177/1099800420907964 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Lascurain-Aguirrebeña I, Newham D, Critchley DJ. Mechanism of Action of Spinal Mobilizations: A Systematic Review. Spine (Phila Pa 1976). 2016;41:159–72. doi: 10.1097/BRS.0000000000001151 . [DOI] [PubMed] [Google Scholar]
  • 71.Galindez-Ibarbengoetxea X, Setuain I, Andersen LL, Ramírez-Velez R, González-Izal M, Jauregi A, et al. Effects of Cervical High-Velocity Low-Amplitude Techniques on Range of Motion, Strength Performance, and Cardiovascular Outcomes: A Review. J Altern Complement Med. 2017;23:667–675. doi: 10.1089/acm.2017.0002 . [DOI] [PubMed] [Google Scholar]
  • 72.Schmid A, Brunner F, Wright A, Bachmann LM. Paradigm shift in manual therapy? Evidence for a central nervous system component in the response to passive cervical joint mobilisation. Man Ther. 2008;13:387–96. doi: 10.1016/j.math.2007.12.007 . [DOI] [PubMed] [Google Scholar]
  • 73.Hegedus EJ, Goode A, Butler RJ, Slaven E. The neurophysiological effects of a single session of spinal joint mobilization: does the effect last? J Man Manip Ther. 2011;19:143–51. doi: 10.1179/2042618611Y.0000000003 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Jänig W, Häbler HJ. Specificity in the organization of the autonomic nervous system: a basis for precise neural regulation of homeostatic and protective body functions. Prog Brain Res. 2000;122:351–67. doi: 10.1016/s0079-6123(08)62150-0 . [DOI] [PubMed] [Google Scholar]
  • 75.Gibbins I. Functional organization of autonomic neural pathways. Organogenesis. 2013;9:169–75. doi: 10.4161/org.25126 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Ghiasi S, Greco A, Barbieri R, Scilingo EP, Valenza G. Assessing Autonomic Function from Electrodermal Activity and Heart Rate Variability During Cold-Pressor Test and Emotional Challenge. Sci Rep. 2020;10:5406. doi: 10.1038/s41598-020-62225-2 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Cowen R, Stasiowska MK, Laycock H, Bantel C. Assessing pain objectively: the use of physiological markers. Anaesthesia. 2015;70:828–47. doi: 10.1111/anae.13018 . [DOI] [PubMed] [Google Scholar]
  • 78.Billman GE. The effect of heart rate on the heart rate variability response to autonomic interventions. Front Physiol. 2013;4:222. doi: 10.3389/fphys.2013.00222 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Weimer LH. Autonomic testing: common techniques and clinical applications. Neurologist. 2010. Jul;16(4):215–22. doi: 10.1097/NRL.0b013e3181cf86ab . [DOI] [PubMed] [Google Scholar]
  • 80.Cheshire WP, Freeman R, Gibbons CH, Cortelli P, Wenning GK, Hilz MJ, et al. Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2021;132:666–682. doi: 10.1016/j.clinph.2020.11.024 Erratum in: Clin Neurophysiol. 2021;132:1194. . [DOI] [PubMed] [Google Scholar]
  • 81.Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043–65. [PubMed] [Google Scholar]
  • 82.Valenzuela PL, Pancorbo S, Lucia A, Germain F. Spinal Manipulative Therapy Effects in Autonomic Regulation and Exercise Performance in Recreational Healthy Athletes: A Randomized Controlled Trial. Spine (Phila Pa 1976). 2019;44:609–614. doi: 10.1097/BRS.0000000000002908 . [DOI] [PubMed] [Google Scholar]
  • 83.Cerritelli F, Chiacchiaretta P, Gambi F, Saggini R, Perrucci MG, Ferretti A. Osteopathy modulates brain-heart interaction in chronic pain patients: an ASL study. Sci Rep. 2021;11:4556. doi: 10.1038/s41598-021-83893-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Petrofsky JS. Control of Skin Blood Flow. In: Farage MA, Miller KW, Maibach HI, editors. Textbook of Aging Skin. Berlin Heidelberg: Springer-Verlag; 2017. p. 1091–1104. [Google Scholar]
  • 85.Seravalle G, Dimitriadis K, Dell’Oro R, Grassi G. How to assess sympathetic nervous system activity in clinical practice. Curr Clin Pharmacol. 2013;8:182–8. doi: 10.2174/1574884711308030003 . [DOI] [PubMed] [Google Scholar]
  • 86.Goldstein DS, Bentho O, Park MY, Sharabi Y. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol. 2011;96:1255–61. doi: 10.1113/expphysiol.2010.056259 Epub 2011 Sep 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Corazza I, Barletta G, Guaraldi P, Cecere A, Calandra-Buonaura G, Altini E, et al. A new integrated instrumental approach to autonomic nervous system assessment. Comput Methods Programs Biomed. 2014;117:267–76. doi: 10.1016/j.cmpb.2014.08.002 . [DOI] [PubMed] [Google Scholar]
  • 88.Bialosky JE, George SZ, Horn ME, Price DD, Staud R, Robinson ME. Spinal manipulative therapy-specific changes in pain sensitivity in individuals with low back pain (NCT01168999). J Pain. 2014;15:136–48. doi: 10.1016/j.jpain.2013.10.005 Epub 2013 Oct 27. . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Iellamo F, Volterrani M, Di Gianfrancesco A, Fossati C, Casasco M. The Effect of Exercise Training on Autonomic Cardiovascular Regulation: From Cardiac Patients to Athletes. Curr Sports Med Rep. 2018;17:473–479. doi: 10.1249/JSR.0000000000000544 . [DOI] [PubMed] [Google Scholar]
  • 90.Lascurain-Aguirrebeña I, Newham DJ, Galindez-Ibarbengoetxea X, Casado-Zumeta X, Lertxundi A, Critchley DJ. Association between sympathoexcitatory changes and symptomatic improvement following cervical mobilisations in participants with neck pain. A double blind placebo controlled trial. Musculoskelet Sci Pract. 2019;42:90–97. doi: 10.1016/j.msksp.2019.05.001 . [DOI] [PubMed] [Google Scholar]
  • 91.Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron. 2014;84:623–37. doi: 10.1016/j.neuron.2014.10.023 . [DOI] [PubMed] [Google Scholar]
  • 92.Bialosky JE, Bishop MD, Penza CW. Placebo Mechanisms of Manual Therapy: A Sheep in Wolf’s Clothing? J Orthop Sports Phys Ther. 2017;47:301–304. doi: 10.2519/jospt.2017.0604 . [DOI] [PubMed] [Google Scholar]
  • 93.Cerritelli F, Verzella M, Cicchitti L, D’Alessandro G, Vanacore N. The paradox of sham therapy and placebo effect in osteopathy: A systematic review. Medicine (Baltimore). 2016;95:e4728. doi: 10.1097/MD.0000000000004728 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Kaptchuk TJ, Miller FG. Placebo Effects in Medicine. N Engl J Med. 2015;373:8–9. doi: 10.1056/NEJMp1504023 . [DOI] [PubMed] [Google Scholar]
  • 95.Colloca L, Jonas WB, Killen J, Miller FG, Shurtleff D. Reevaluating the placebo effect in medical practice. Z Psychol. 2014;222:124–127. doi: 10.1027/2151-2604/a000177 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev. 2013;93:1207–46. doi: 10.1152/physrev.00043.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Benedetti F. Receiving the therapy: the activation of expectation and placebo mechanisms. In: Benedetti F. The Patient’s Brain: The neuroscience behind the doctor-patient relationship. Oxford: Oxford University Press; 2013. doi: 10.1093/med/9780199579518.003.0006 [DOI] [Google Scholar]
  • 98.Rossettini G, Carlino E, Testa M. Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. BMC Musculoskelet Disord. 2018;19:27. doi: 10.1186/s12891-018-1943-8 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3:655–66. doi: 10.1038/nrn894 . [DOI] [PubMed] [Google Scholar]
  • 100.Riley SP, Swanson B, Brismée JM, Sawyer SF. A systematic review of orthopaedic manual therapy randomized clinical trials quality. J Man Manip Ther. 2016;24:241–252. doi: 10.1080/10669817.2015.1119372 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Gonzalez GZ, Moseley AM, Maher CG, Nascimento DP, Costa LDCM, Costa LO. Methodologic Quality and Statistical Reporting of Physical Therapy Randomized Controlled Trials Relevant to Musculoskeletal Conditions. Arch Phys Med Rehabil. 2018;99:129–136. doi: 10.1016/j.apmr.2017.08.485 . [DOI] [PubMed] [Google Scholar]
  • 102.Bertizzolo L, Bossuyt P, Atal I, Ravaud P, Dechartres A. Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design. BMJ Open. 2019;9:e028382. doi: 10.1136/bmjopen-2018-028382 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Moseley AM, Rahman P, Wells GA, Zadro JR, Sherrington C, Toupin-April K, et al. Agreement between the Cochrane risk of bias tool and Physiotherapy Evidence Database (PEDro) scale: A meta-epidemiological study of randomized controlled trials of physical therapy interventions. PLoS One. 2019;14:e0222770. doi: 10.1371/journal.pone.0222770 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Bayo-Tallón V, Esquirol-Caussa J, Pàmias-Massana M, Planells-Keller K, Palao-Vidal DJ. Effects of manual cranial therapy on heart rate variability in children without associated disorders: Translation to clinical practice. Complement Ther Clin Pract. 2019;36:125–141. doi: 10.1016/j.ctcp.2019.06.008 . [DOI] [PubMed] [Google Scholar]
  • 105.Curi ACC, Maior Alves AS, Silva JG. Cardiac autonomic response after cranial technique of the fourth ventricle (cv4) compression in systemic hypertensive subjects. J Bodyw Mov Ther. 2018;22:666–672. doi: 10.1016/j.jbmt.2017.11.013 . [DOI] [PubMed] [Google Scholar]
  • 106.Greenhalgh T, Howick J, Maskrey N; Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725. doi: 10.1136/bmj.g3725 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. ; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Linson A, Clark A, Ramamoorthy S, Friston K. The Active Inference Approach to Ecological Perception: General Information Dynamics for Natural and Artificial Embodied Cognition. Front Robot AI. 2018;5:21. doi: 10.3389/frobt.2018.00021 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Schloemer T, Schröder-Bäck P. Criteria for evaluating transferability of health interventions: a systematic review and thematic synthesis. Implement Sci. 2018;13:88. doi: 10.1186/s13012-018-0751-8 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Minary L, Trompette J, Kivits J, Cambon L, Tarquinio C, Alla F. Which design to evaluate complex interventions? Toward a methodological framework through a systematic review. BMC Med Res Methodol. 2019;19:92. doi: 10.1186/s12874-019-0736-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Sacristán JA, Dilla T. Pragmatic trials revisited: applicability is about individualization. J Clin Epidemiol. 2018;99:164–166. doi: 10.1016/j.jclinepi.2018.02.003 . [DOI] [PubMed] [Google Scholar]
  • 112.Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009;10:37. doi: 10.1186/1745-6215-10-37 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Andrianome S, Gobert J, Hugueville L, Stéphan-Blanchard E, Telliez F, Selmaoui B. An assessment of the autonomic nervous system in the electrohypersensitive population: a heart rate variability and skin conductance study. J Appl Physiol (1985). 2017;123:1055–1062. doi: 10.1152/japplphysiol.00229.2017 . [DOI] [PubMed] [Google Scholar]
  • 114.Alvarez G, Cerritelli F, Urrutia G. Using the template for intervention description and replication [TIDieR] as a tool for improving the design and reporting of manual therapy interventions. Man Ther. 2016;24:85–9. doi: 10.1016/j.math.2016.03.004 [DOI] [PubMed] [Google Scholar]
  • 115.Goossen K, Hess S, Lunny C, Pieper D. Database combinations to retrieve systematic reviews in overviews of reviews: a methodological study. BMC Med Res Methodol. 2020;20:138. doi: 10.1186/s12874-020-00983-3 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Banzi R, Cinquini M, Gonzalez-Lorenzo M, Pecoraro V, Capobussi M, Minozzi S. Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability. J Clin Epidemiol. 2018;99:24–32. doi: 10.1016/j.jclinepi.2018.02.024 . [DOI] [PubMed] [Google Scholar]
  • 117.Pieper D, Puljak L, González-Lorenzo M, Minozzi S. Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic reviews including both randomized and nonrandomized studies. J Clin Epidemiol. 2019;108:26–33. doi: 10.1016/j.jclinepi.2018.12.004 . [DOI] [PubMed] [Google Scholar]
  • 118.Pieper D, Antoine SL, Neugebauer EA, Eikermann M. Up-to-dateness of reviews is often neglected in overviews: a systematic review. J Clin Epidemiol. 2014;67:1302–8. doi: 10.1016/j.jclinepi.2014.08.008 Epub 2014 Oct 1. . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Andrej M Kielbassa

6 Sep 2021

PONE-D-21-24377Do manual therapies have a specific autonomic effect? An overview of systematic reviews.PLOS ONE

Dear Dr. Roura,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Having intensively reviewed your revised draft, our external reviewers differed with their final recommendations, at least to some extent. Thus, I have double checked your revised version, to come to a more balanced decision (see R #1). All in all, our  identified shortcomings are considered reasonable with regard to both PLOS ONE’s quality standards and our readership's expectations. Therefore, we invite you to submit a carefully revised version of the manuscript that addresses EACH AND EVERY point raised during the current review process. Please note that a non-convincing revision (not considered acceptable with regard to language, content, reviewers' constructive criticisms, generalizable conclusions, and/or Authors' Guidelines) must lead to outright reject. 

Please submit your revised manuscript by Oct 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Andrej M Kielbassa

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

 [Funding for the publication of this article was provided by Registro de Osteopatas de España (ROE) www.osteopatas.org].  

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4. Please include a separate caption for each figure in your manuscript.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a review of systematic reviews. I have no comments to the authors. The only thing is checking the file uploading since tables are mixed with text and it has been difficult to review the paper. Authors could explain why they have not conducted an umbrella meta-analysis.

Reviewer #2: General remarks

- In formulating the scope for a review of reviews, the PICOS (participants, interventions, comparators, outcomes, and study design) structure is considered helpful. Please revise accordingly.

- Please note that there are various evidence levels with recent research papers. Consequently, a Systematic Review of Level I would include only Level-I Randomised Controlled Studies. No doubt, a Level-I Overview of Systematic Reviews must include Level-I Systematic Reviews only. It would not make sense to re-repeat poor RCTs, and to re-repeat poor Systematic Reviews based on poor RCTs.

- Please remember that Plos One's mission is "to publish methodologically and ethically rigorous research". Would it be sound from a methodological point of view to include papers based on poor quality? No, it wouldn't. Would it be sound from an ethical point of view to draw any conclusions based on such papers? Again, no, it wouldn't, too. But this clearly would render your "rigorous" research doubtful.

- What about using the AMSTAR tool as a means to assess the methodological quality of systematic reviews?

- What about using the GRADE approach with your ‘Summary of Findings’?

Abstract

- Please note that the allowed maximum word count with this section is 300. Please shorten considerably.

- Note all repositories have been used. Please provide reasons.

- "Two overview authors independently applied the selection criteria (...)." Please define the "selection criteria".

- "Our search identified 557 records, from which we included 12 reviews." No word about the quality of those 12 papers? Remember that just including 12 retrievable papers would not seem satisfying.

- "Moreover, the clinical relevance of those results are still unclear." Reasons remain unclear.

- "Future research should consider some key elements proposed to overcome common shortcomings and include ways to improve the quality and applicability of the results." This is not considered a conclusion referring to your aims; instead (as with most other topics), this would have been clear prior to the start of your project.

Intro

- Again, please stick to the Authors' Guidelines. "(...) body’s internal environment (homeostasis) (1,2)." must read "(...) body’s internal environment (homeostasis) [1,2]." Revise thoroughly.

- "Recent systematic reviews have shown that the MT approach is clinically effective (...)." and "iMoreover, several clinical studies have shown the effectiveness of MT (...)." Please see comments given above, and add information on the quality level of the referenced papers. Just "being published" is not considered a quality aspect.

- Same with "Evidence about autonomic effects of manual therapy interventions is synthesized within many reviews (41–46,48,49)." Again, provide detailed information, and revise carefully.

Meths

- Did you note that your "Objectives" (aims) do not fully correspond to your Abstract section?

- regarding your inclusion criteria, please see comments given above. Revise carefully, and include aspects of utmost quality.

- "Cochrane Library, PubMed, EPISTEMONIKOS, and SCOPUS" would not seem exhaustive. Why didn't you include other databases? What about foreign languages? What about the grey literature?

- "Two authors (SR and GA) independently assessed titles and abstracts of records identified by the electronic searches according to the inclusion criteria and decided on eligibility obtaining a full text copy from relevant references." Indeed, the two authors obviously simply searched. Again, what about the quality level of the included papers?

- "We solved disagreements involving a third author (FC) to reach a consensus through discussion." What kind of "disagreements" are you talking about? How often have there been "disagreements"? Was a consensus possible in all cases? And, again, what about the agreements regrading the quality levels?

Results

- "All the reviews included randomized clinical trials (RCTs), one also included quasi-RCTs, four included non-randomized trials and two other designs." Again, see comments given above. "Quasi-RCTs, non-randomized trials and other designs" would not confirm Level-I research. Why did you include such papers?

- With your Table 2 ("Characteristics of the included reviews"), please add your quality assessment. Again, please do not simply add the published papers; instead provide a sound, a valid, and a reasonable quality assessment, to allow to distinguish high- from poor-level papers.

- Do not use Authors' names with your text, see "Schmid et al. found conflicting evidence (69).".

- There would seem some errors to be evident. See "and after mobilisations (41,45) and in the diastolic blood pressure after neck manipulations (Schmid et al. 2008)."

- Same with "Galindez et al. found a decrease in systolic BP in hypertensive type I subjects but not in healthy participants (Galindez et al 2016). Two studies found an increase in HR after mobilisations (49,67), and one found no effect after cervical manipulation (Galindez et al 2017)." revise carefully.

- "Different quality assessment tools were used among the SRs (Appendix 4), showing a high heterogeneity of the studies' quality." See comments given above. First, the quality of the reviews would seem more important than the contents, to decide whether the paper will be included. Second, the results of your quality assessment must be provided here, and NOT somewhere in an Appendix.

- From your Table 9 (!) it finally becomes clear that you ONLY found 1 (!) paper of "high quality". This would not seem convincing, not at all.

- Revise thoroughly for minor typos, see ""(...) are considered. (30,76,112)."

- Again, do not use Authors' names, see "This tool is highly recommended when performing overviews or clinical guidelines (Whiting et al.)."

- "The difference between those with low risk of bias and those with unclear risk of bias was due to the poor reporting of information, lack of protocol registration and methodological deficiencies." OK, but this would not seem an acceptable excuse.

- "Our overview identified a high heterogeneity in regards to the quality of the articles included." Again, this would mean that papers with poor quality have been included. This must be elaborated more clearly. Moreover, it does not make sense to re-re-repeat those poor quality papers. With your revision, please stick exclusively to the Level-I papers. This refers to your conclusions. Papers with poor quality might be mentioned, but the drawbacks must be elucidated clearly.

- "Consistent with the literature, the studies included in the present overview revealed the same issues, such as high heterogeneity, reporting deficiencies and the same articles rated differently." So please explain why you have included those papers? What about excluding such RCTs/systematic reviews? Remember that your write for the readers. What should a reader think after having swallowed your overview?

- Please separate your "Suggestions" from the "Conclusions".

- Do not mix "Conclusions" and "Recommendations". All these aspects might be right, but do not mix it up, please.

Refs

- Stick exclusively to the Journal style, and revise for uniform formatting. Again and again, you state "[Internet]" and "Available from"; please delete. Consult some recently published Plos One papers. Provide doi and PMID numbers.

Concl

- With your Conclusions, please stick exclusively to your revised aims. Do not simply repeat your results here. Do not give a further literature review here. Instead, provide a reasonable and generalizable extension of your outcome.

All in all, this submitted draft would seem interesting, is considered easily intelligible and would seem worth following after a thorough revision, considering all the aspects indicated above.

Reviewer #3: I congratulate the authors for their work. The review addresses a relevant topic with important gaps in the literature. The compression of the mechanisms of effect of manual techniques is fundamental for the most adequate clinical reasoning and for the scientific advance in this subject. In fact, the relationship between autonomic effects and clinical improvement is an important gap in the literature. The large number of reviews on the subject can confuse readers and the authors knew how to unify the main findings of the studies in a very adequate way. However, I suggest better synthesizing the ideas in the introduction and discussion to reduce the scope of the work. Below are other small suggestions

Intro:

1. Overall the introduction is very complete, but excessively detailed and long. Theoretically, readers interested in the topic should already have a basic knowledge of the topic, or they can consult the bibliographic references for further details. I suggest reducing paragraphs, or even unifying some (the second and third could unify action mechanisms - and gaps in these mechanisms - of manual therapy, without the need for so many explanations about the definition and clinical conditions that this area usually deals with - theme of the second paragraph )

Methods:

2. The authors describe that they considered the level of evidence described in the reviews included, as well as the methodological quality of the studies included in the reviews, for the generalization of evidence. However, the criteria used to summarize the level of evidence of the findings were not clear. I suggest defining a better instrument for this, something like the GRADE approach or similar.

Results:

3. Due to the amount of information (due to the large number of studies and variables), I suggest deleting the "newspaper" column from Table 2.

4. Table 5. Review by Araujo et al, it seems that they would be "Intervertebral mobilisations" or "mobilisations" only, and not both. In this same table, some words in the techniques column are capitalized and others are not.

Discussion:

5. As the introduction, the discussion is too long. Due to the number of studies and research questions, the results are already extensive. I suggest summarizing the main topics both in the introduction and in the discussion. Many discussion topics have already been covered in the results. I suggest organizing the discussion more broadly (without so many sections). I suggest organizing the discussion according to the following topics: main findings; strenghts and limitations; comparison with previous studies; meaning of the study (clinical message and future directions).

6. I see no reason for the authors to report results from more recently published RCTs….out of the scope of the study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Francisco Xavier de Araujo

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Dec 2;16(12):e0260642. doi: 10.1371/journal.pone.0260642.r002

Author response to Decision Letter 0


14 Oct 2021

Comments Responses

Rev#1

This is a review of systematic reviews. I have no comments to the authors. The only thing is checking the file uploading since tables are mixed with text and it has been difficult to review the paper. Authors could explain why they have not conducted an umbrella meta-analysis

Thank you to Rev#1, the tables were included directly after the paragraph in which they were first cited, as suggested by the PLOS ONE author guidelines. However, we agree that it is difficult to review the paper with the tables in the middle of the text due to their size and quantity. We updated the manuscript and included all tables at the end.

The choice to perform an overview instead of an umbrella meta-analysis was because:

1) The goal was to map, synthesise and explore discrepancies in the available systematic reviews

2) The scope of the research question is broad, with high heterogeneity among participants, outcomes and interventions

3) Because our objective is consistent with the one stated in Cochrane Handbook chapter V for Overview:: “The primary reason for conducting Cochrane Overviews is that using systematic reviews as the unit of searching, inclusion, and data analysis allows authors to address research questions that are broader in scope than those examined in individual systematic reviews and in cases where it is important to understand the diversity present in the extant systematic review literature”

Rev#2

General comment to “General remarks” from Rev#2

We are grateful for the effort made to review our manuscript and for highlighting some points that have contributed to improving the reporting of our findings.

We also would like to open a discussion about the approach of the reviewer to the overview and the scientific literature summarized in the study. The reviewer focuses many of his / her comments on levels of evidence and the appropriateness to consider ‘poor quality’ (sic) studies when conducting an evidence synthesis. The former argument led the reviewer to question if our overview has been conducted according to a sound methodology (and fit, in the end, with the PLOS ONE mission).

In that sense, we submitted our manuscript to PLOS ONE being aware of its mission and instructions for (candidate) authors. Moreover, we submitted the manuscript convinced that we accomplished with the most recent standards for conducting overviews (summarised in Chapter V from the Cochrane Handbook for Systematic Reviews of Interventions or in Gates M doi: 10.1186/s13643-020-01509-0). We conducted the overview according to these methodological standards and will refer to them in responding to most of the reviewer’s comments.

It is necessary to disclose that we consider the discourse around ‘levels of evidence’ outdated. Classifications and discussions based on levels of evidence are restrictive and, due to its focus on study designs and hierarchies, does not allow to analyse additional issues such as the consistency of a body of evidence, its breadth or the overlap of its scope (some has provided more discussion on this issue (doi: 10.1136/bmj.c4875)). At the very end the focus on levels of evidence can result in an epistemological bias that confers confidence in the goodness of a determinate study design (or, more worrying, to its position in a hierarchy).

Recently the science of evidence synthesis has evolved to a more comprehensive approach to methodological challenges related to the necessity to deal with the limitations from the existing literature (and their implications to future research and practice) or allowing researchers to analyse the overlap within existing reviews.

Specifically, overviews are an excellent tool to summarise the breadth of research to obtain a picture of the overall completeness and applicability of the body of evidence included in the original reviews. Researchers have the commitment to accurately assess, analyse and interpret the threats for the validity of the primary studies included in eligible reviews and are responsible to present the findings of their overviews warning readers, when necessary, about the limitations of the existing evidence.

The reviewer expressed his / her concern on “what should a reader think after having swallowed [our] overview”. We sincerely hope that the arguments above could contribute to clarify the methodological framework of our overview.

In formulating the scope for a review of reviews, the PICOS (participants, interventions, comparators, outcomes, and study design) structure is considered helpful. Please revise accordingly.

Thank you for this comment; A better structure for the scope of the overview has been added in the Inclusion Criteria section page 6 lines 159-209

Please note that there are various evidence levels with recent research papers. Consequently, a Systematic Review of Level I would include only Level-I Randomised Controlled Studies. No doubt, a Level-I Overview of Systematic Reviews must include Level-I Systematic Reviews only. It would not make sense to re-repeat poor RCTs, and to re-repeat poor Systematic Reviews based on poor RCTs.

We provide a detailed rationale for this issue at the “General comment to “General remarks” from Rev#2”.

However, we have modified table 2 (characteristics of the reviews included), table 4 (Risk of bias of included SRs), table 5 (Summary of findings) and table 9 (Generalization of the evidence) and the main text to make more clear rationale:

Main text page 11 line 375-382, 477-497

Table 2 has been modified in order to clarify the methodological characteristics of the included SRs. Page 43

Table 5 “summary of findings”: we have merged tables 5 and 6 adding a column with the GRADE assessment made by the SRs. Page 50

Table 9. Outline of generalization of the evidence, summarizes the questions that this overview wants to answer within each SR taking into account the methodological quality assessed by ROBIs, a coloured column in green has been added to improve the visibility of the importance given to the higher quality SRs included for answering the questions. Page 61

Please remember that Plos One's mission is "to publish methodologically and ethically rigorous research". Would it be sound from a methodological point of view to include papers based on poor quality? No, it wouldn't. Would it be sound from an ethical point of view to draw any conclusions based on such papers? Again, no, it wouldn't, too. But this clearly would render your "rigorous" research doubtful.

What about using the AMSTAR tool as a means to assess the methodological quality of systematic reviews?

Current guidance to conduct overviews does not reach a consensus on the ideal tool to appraise the validity of included reviews (doi: 10.1186/s13643-020-01509-0). Many published methodological frameworks to conduct reviews mention AMSTAR, but most recent guidance emphasises on ROBIS.

Chapter V from the Cochrane Handbook for Systematic Reviews does not recommend one tool over another due to the lack of empirical evidence about their performance (https://training.cochrane.org/handbook/current/chapter-v#section--4). Besides, Cochrane provides specific guidance to use domain-based tools when assessing the risk of bias of included studies in a review. As ROBIS is conceived from this approach (domain-based tools) we made the decision to use this tool.

A sentence has been added to clarify this point. Page 24 lines 860-865

What about using the GRADE approach with your ‘Summary of Findings’?

We agree that including judgements on certainty of evidence would be informative, but there is no formal guidance to use GRADE for overviews. Besides, GRADE encourages the assessment of outcomes that have a direct impact on decision making and our clinical question could be, in part, out of its scope.

We have included a comment in the discussion related to this issue .Page 24 lines 877-879

Abstract

Please note that the allowed maximum word count with this section is 300. Please shorten considerably. Thank you for this comment, Abstract has been shortened considerably

Note all repositories have been used. Please provide reasons. Recent data show that the best combination to identify SR in the context of overviews is to search MEDLINE and Epistmonikos complemented with reference checking (DOI: 10.1186/s12874-020-00983-3).

We complemented this guidance with searches in scopus and WoS (the former, to track citations to relevant reviews).

We added a sentence at the ‘Potential biases …’ section (page 24 lines 854-858) to remark the exhaustiveness of the search strategy.

"Two overview authors independently applied the selection criteria (...)." Please define the "selection criteria" Selection criteria are already defined in the abstract, page 2 lines 27-29

"Our search identified 557 records, from which we included 12 reviews." No word about the quality of those 12 papers? Remember that just including 12 retrievable papers would not seem satisfying. This is an important point. Amended: The sentence “Five out of 12 SRs were rated as low risk of bias when assessed with ROBIS tool.” has been added to the Abstract Results section page 2 line 33

"Moreover, the clinical relevance of those results are still unclear." Reasons remain unclear. Amended, page 2 lines 38-41

"Future research should consider some key elements proposed to overcome common shortcomings and include ways to improve the quality and applicability of the results." This is not considered a conclusion referring to your aims; instead (as with most other topics), this would have been clear prior to the start of your project. We agree with the reviewer that suggestions should go separately from conclusions. This has been changed and removed from conclusions either in the abstract and in the main text. However, an overview design can include in its structure a “suggestions for further research” section, for this reason, we find it very interesting for the reader and future research to summarise some key points to take into account when conducting research in ANS and MT field and overcome common shortcomings.

Page 2 line 39, page 24 line 878

Intro

Again, please stick to the Authors' Guidelines. "(...) body’s internal environment (homeostasis) (1,2)." must read "(...) body’s internal environment (homeostasis) [1,2]." Revise thoroughly. Thank you for this clarification. Amended through all the manuscript

"Recent systematic reviews have shown that the MT approach is clinically effective (...)." and "iMoreover, several clinical studies have shown the effectiveness of MT (...)." Please see comments given above, and add information on the quality level of the referenced papers. Just "being published" is not considered a quality aspect.

Thank you for this comment, text has been changed and adapted to the reviewer suggestion.

Page 3 line 76

Same with "Evidence about autonomic effects of manual therapy interventions is synthesised within many reviews (41–46,48,49)." Again, provide detailed information, and revise carefully. Thank you for this clarification, Amended: references 41, 42,44 and 48 have been removed as they were rate as unclear RoB in our quality methodological assessment

page 4 line 125

Methods

Did you note that your "Objectives" (aims) do not fully correspond to your Abstract section? Thank you for this clarification, corrections have been amended in the Abstract page 2 lines 20-21

regarding your inclusion criteria, please see comments given above. Revise carefully, and include aspects of utmost quality. We established eligibility criteria to ensure the inclusion of reviews conducted according to rigorous standards. We defined the characteristics of eligible systematic reviews according to specific characteristics discussed recently (DOI: 10.1186/s12874-019-0855-0).

We added a sentence at the ‘Potential biases …’ section (page 24 lines 858-860) to remark the appropriateness of our inclusion criteria.

"Cochrane Library, PubMed, EPISTEMONIKOS, and SCOPUS" would not seem exhaustive. Why didn't you include other databases? What about foreign languages? What about the grey literature? Recent data show that the best combination to identify SR in the context of overviews is to search MEDLINE and Epistmonikos complemented with reference checking (DOI: 10.1186/s12874-020-00983-3).

We complemented this guidance with searches in scopus and WoS (the former, to track citations to relevant reviews).

We added a sentence at the ‘Potential biases …’ section (page 24 lines 854-858) to remark on the exhaustiveness of the search strategy.

"Two authors (SR and GA) independently assessed titles and abstracts of records identified by the electronic searches according to the inclusion criteria and decided on eligibility obtaining a full text copy from relevant references." Indeed, the two authors obviously simply searched. Again, what about the quality level of the included papers? We are compelled to disagree with this comment. At this step of evidence syntheses (SR, overviews and others) the search is completed, and researchers have to make decisions regarding study eligibility. It is recommended that at least two reviewers independently compare the reference yield by the search against inclusion criteria. We report this methodological standard according to the PRISMA statement (DOI: 10.1136/bmj.n71), as no specific reporting standards exist at the moment (the PRIOR statement is still in progress; DOI: 10.1186/s13643-019-1252-9)

"We solved disagreements involving a third author (FC) to reach a consensus through discussion." What kind of "disagreements" are you talking about? How often have there been "disagreements"? Was a consensus possible in all cases? And, again, what about the agreements regrading the quality levels? We have re-worded this sentence to be more specific. Quality issues do not apply at this step. We report this methodological standard according to the PRISMA statement (DOI: 10.1136/bmj.n71). Page 7 lines 228-230

Results

"All the reviews included randomised clinical trials (RCTs), one also included quasi-RCTs, four included non-randomised trials and two other designs." Again, see comments given above. "Quasi-RCTs, non-randomised trials and other designs" would not confirm Level-I research. Why did you include such papers? We provide a detailed rationale for this issue at the “General comment to “General remarks” from Rev#2”.

One of the functions of overviews is to provide a scope of the body of evidence that is included within the eligible reviews. Overview protocols have to establish inclusion criteria for the eligible systematic reviews but not for the primary research that they include. Overviews have to describe the characteristics of included reviews and critically synthesize their findings. We provided a detailed discussion on the limitations from original research included into the eligible reviews and provide a rationale for their implications.

With your Table 2 ("Characteristics of the included reviews"), please add your quality assessment. Again, please do not simply add the published papers; instead provide a sound, a valid, and a reasonable quality assessment, to allow to distinguish high- from poor-level papers. Amended: as suggested, table 2 has been modified and the RoB assessment of included SRs has been included. Page 43

Do not use Authors' names with your text, see "Schmid et al. found conflicting evidence (69)." Thank you for this clarification, Author’s names have been removed and replaced.

There would seem some errors to be evident. See "and after mobilisations (41,45) and in the diastolic blood pressure after neck manipulations (Schmid et al. 2008)." Amended page 13 lines 460, 463

Same with "Galindez et al. found a decrease in systolic BP in hypertensive type I subjects but not in healthy participants (Galindez et al 2016) Two studies found an increase in HR after mobilisations (49,67), and one found no effect after cervical manipulation (Galindez et al 2017)." revise carefully. Amended page 13

"Different quality assessment tools were used among the SRs (Appendix 4), showing a high heterogeneity of the studies' quality." See comments given above. First, the quality of the reviews would seem more important than the contents, to decide whether the paper will be included. Second, the results of your quality assessment must be provided here, and NOT somewhere in an Appendix. We have reformulated the table that describes the included reviews and the text to be clearer about this issue (both in the results and discussion sections). Again, the argument in this point is not if reviews should be included according to their bias or the bias of the primary research that they include. The overview has to make a clear picture of the reviews available to inform a clinical question and the scientific rigour behind them, and then discuss the implications for research and practice of such a body of evidence.

Table 4 page 49 (Risk of bias assessment of the included reviews (ROBIS)) + Sup 3 Table

Page 22 lines 773-777

From your Table 9 (!) it finally becomes clear that you ONLY found 1 (!) paper of "high quality". This would not seem convincing, not at all This comment is due to an (unwitting) misconception of domain-based approaches to assess the risk of bias. The judgements in the table refer to the risk of bias from included reviews, not to the quality of them.

We discussed this issue further above (choice of ROBIS instead of AMSTAR).

We have labelled “risk of bias of included reviews” the headings in the manuscript that could be a source of confusion.

On the other hand, a reformulated table 9 (now table 4) has been included to avoid semantic misconception of this construct. Page 49

Revise thoroughly for minor typos, see ""(...) are considered. (30,76,112)." Amended Page 21 line 754

Again, do not use Authors' names, see "This tool is highly recommended when performing overviews or clinical guidelines (Whiting et al.). Amended Page 21 line 760

"The difference between those with low risk of bias and those with unclear risk of bias was due to the poor reporting of information, lack of protocol registration and methodological deficiencies." OK, but this would not seem an acceptable excuse. Good point to extend, some information regarding the methodological deficiencies of the SRs rated as UNCLEAR RoB has been added on page 21 line 771.

"Our overview identified a high heterogeneity in regards to the quality of the articles included." Again, this would mean that papers with poor quality have been included. This must be elaborated more clearly. Moreover, it does not make sense to re-re-repeat those poor quality papers. With your revision, please stick exclusively to the Level-I papers. This refers to your conclusions. Papers with poor quality might be mentioned, but the drawbacks must be elucidated clearly. Please, see the comment below

"Consistent with the literature, the studies included in the present overview revealed the same issues, such as high heterogeneity, reporting deficiencies and the same articles rated differently." So please explain why you have included those papers? What about excluding such RCTs/systematic reviews? Remember that your write for the readers. What should a reader think after having swallowed your overview? Although we are aware that there are groups that encourage overview authors to include only high quality reviews, we also agree that this decision may introduce bias (doi: 10.1186/s13643-020-01509-0), specifically when the overview aims to scope the body of the evidence that informs a clinical question.

As we anticipated the topic of interest of our clinical question was assessed in several systematic reviews, we planned to conduct the overview to comprehensively identify them and then accurately appraise their bias and overlap. The process allowed us to map the existing reviews and the original research on this field and to develop a discussion on implications on the generability of available evidence.

Please separate your "Suggestions" from the "Conclusions". Amended

Do not mix "Conclusions" and "Recommendations". All these aspects might be right, but do not mix it up, please.

Good clarification, amended

Refs

- Stick exclusively to the Journal style, and revise for uniform formatting. Again and again, you state "[Internet]" and "Available from"; please delete. Consult some recently published Plos One papers. Provide doi and PMID numbers.

We apologise for this inconvenience and references have been amended as suggested.

Concl

- With your Conclusions, please stick exclusively to your revised aims. Do not simply repeat your results here. Do not give a further literature review here. Instead, provide a reasonable and generalisable extension of your outcome.

Information according to aims has been added to the conclusions section, Page 22 lines 805-810

Reviewer #3

I congratulate the authors for their work. The review addresses a relevant topic with important gaps in the literature. The compression of the mechanisms of effect of manual techniques is fundamental for the most adequate clinical reasoning and for the scientific advance in this subject. In fact, the relationship between autonomic effects and clinical improvement is an important gap in the literature. The large number of reviews on the subject can confuse readers and the authors knew how to unify the main findings of the studies in a very adequate way. However, I suggest better synthesising the ideas in the introduction and discussion to reduce the scope of the work. Below are other small suggestions

We appreciate this comment from reviewer #3

Intro

1. Overall the introduction is very complete, but excessively detailed and long. Theoretically, readers interested in the topic should already have a basic knowledge of the topic, or they can consult the bibliographic references for further details. I suggest reducing paragraphs, or even unifying some (the second and third could unify action mechanisms - and gaps in these mechanisms - of manual therapy, without the need for so many explanations about the definition and clinical conditions that this area usually deals with - theme of the second paragraph ) We agree with the reviewer about the excessively detailed and long introduction. We understand that readers already interested in this topic may have basic knowledge on that, however, our intention when trying to publish in PLOS One journal was to broaden the audience to those that might be naïve to the topic. Is for this reason that we carefully considered introducing the topic for those who might find it hard to go through the references to have an idea of the importance of MT effects on ANS.

Methods

2. The authors describe that they considered the level of evidence described in the reviews included, as well as the methodological quality of the studies included in the reviews, for the generalisation of evidence. However, the criteria used to summarise the level of evidence of the findings were not clear. I suggest defining a better instrument for this, something like the GRADE approach or similar. We agree that including judgements on the certainty of evidence would be informative, but there is no formal guidance to use GRADE for overviews. Besides, GRADE encourages the assessment of outcomes that have a direct impact on decision making and our clinical question could be, in part, out of its scope.

We have included a comment in the discussion related to this issue. Page 24 lines 869-865

On the other hand, we have clarified the efforts to appraise the body of evidence included in the eligible reviews by appraising their overlap and risk bias.

Results

3. Due to the amount of information (due to the large number of studies and variables), I suggest deleting the "newspaper" column from Table 2. Thank you, amended. Table 2 has been modified. page 43

4. Table 5. Review by Araujo et al, it seems that they would be "Intervertebral mobilisations" or "mobilisations" only, and not both. In this same table, some words in the techniques column are capitalised and others are not. Thank you for this clarification, amended.

Discussion

5. As the introduction, the discussion is too long. Due to the number of studies and research questions, the results are already extensive. I suggest summarising the main topics both in the introduction and in the discussion. Many discussion topics have already been covered in the results. I suggest organising the discussion more broadly (without so many sections). I suggest organising the discussion according to the following topics: main findings; strenghts and limitations; comparison with previous studies; meaning of the study (clinical message and future directions).

We understand the general feeling of being a long manuscript, however, an overview of SRs entails a deep assessment of all data available. This fact makes it difficult to synthesise and for this reason, the authors decided to structure the discussion into 4 different parts. In addition, to fully understand the autonomic effects it is necessary to distinguish each effect depending on the autonomic markers used and to discuss the appropriateness of each marker. The introduction section length has been justified in the first comment. Is for this reason that we would prefer to let both sections be like this.

6. I see no reason for the authors to report results from more recently published RCTs….out of the scope of the study. We understand this comment that discussing results from recently published RCTs is out of the scope of the study. However, in the Overview design structure, there is a place to discuss agreements and disagreements with other studies or reviews. Also, we considered including useful information from very recent RCT’s in this field relevant.

Journal Requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming Done

Thank you for stating the following financial disclosure:

[Funding for the publication of this article was provided by Registro de Osteopatas de España (ROE) www.osteopatas.org].

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Done

We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Data availability will be upon request

Please include a separate caption for each figure in your manuscript.

Amended

Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly.

Amended

Attachment

Submitted filename: Responses to reviewers.docx

Decision Letter 1

Andrej M Kielbassa

1 Nov 2021

PONE-D-21-24377R1Do manual therapies have a specific autonomic effect? An overview of systematic reviews.PLOS ONE

Dear Dr. Roura,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Having intensively reviewed your revised draft, our external reviewers agreed with their final recommendations. Additionally, I have double checked your revised version, to come to a final decision (see R #1). All in all, I am convinced that your revised paper will be worth following, even if your revised version still would benefit from minor and major re-edits and some polishing.

Please submit your revised manuscript by Dec 16 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Andrej M Kielbassa

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All comments have been addressed by the authors making the paper acceptable for publication in its current form

Reviewer #2: General remark

- This revised and re-subitted draft has considerably improved.

- Moreover, the Authors have thoroughly responded to this reviewer's previous comments. Their thoughts would seem comprehensible, even if some few positions are considered debatable. The future readers will decide on those aspects.

- Unfortunately, still some aspects are in need of revision. Please see below, and remember that this is not the right place to persistently insist on prevailing your ideas.

Abstract

- Again, please stick to Journal guidelines. Maximum word count is 300 (but NOT 399!). Please revise carefully. Remember that your answer ("Thank you for this comment, Abstract has been shortened considerably") would not seem satisfying.

- Again, please adapt aims given with the Abstract section and the questions asked in the Introduction section. This reviewer has read your comments ("Thank you for this clarification, corrections have been

amended in the Abstract page 2 lines 20-21"), but still there would be some need to polish this topic.

- Remember that with your conclusions, answers must be given exclusively to your questions.

Introduction

- Please see comments given above.

Materials and Methods

- Heading must read "Materials and methods". Again, please stick to the Journal guidelines, and consult some recently published Plos One papers. "METHODS" would not seem acceptable. Remember that there will not be any thorough copy editing, so only flawless papers will be acceptable.

- As a general recommendation, please stick to Journal style with ALL other aspects. For example, you repeatedly refer to "table 2", "table 3", "table 4", and so on. Again, please consult some recently published Plos One papers, there you will see that this must read "Table (1, 2, 3, or 4)". Same with other minor aspects, please revise carefully, and remember that submitting a flawless manuscript is considered the Authors' task, and that the typesetter will not be able to copy edit your draft.

Conclusions

- Do not give a "summary" here. For example, "There is considerable research (...)" and "This overview summarized the information reported by 12 systematic reviews." are not considered conclusions.

- Again, with your Conclusions section, please stick exclusively to your revised aims. Do not simply repeat your results here. Instead, provide a reasonable and generalizable extension of your outcome.

- Same thoughts are valid for "Implications for research: (...)". These aspects surely would seem right, and should be transferable to the Discussion section. However (and again), those thoughts are not considered Conclusions. Again, please revise carefully.

References

- Again, revise for uniform formatting. Stick to Journal style. Provide doi and PMID numbers. Again, the Authors' response ("We apologise for this inconvenience and references have been amended as suggested.") would not seem satisfying.

- Example would be: "Cheng L, Weir MD, Xu HH, Antonucci JM, Lin NJ, Lin-Gibson S, et al. Effect of amorphous calcium phosphate and silver nanocomposites on dental plaque microcosm biofilms. J Biomed Mater Res B Appl Biomater. 2012; 100(5): 1378–1386. https://doi.org/10.1002/jbm.b.32709 PMID: 22566464" Revise thoroughly, but carefully. Remember that it is not the idea to re-re-review your submitted draft, and another re-submission not considered satisfying would lead to "outright rejection".

In total, this revised and resubmitted draft still is not considered ready to proceed. The Authors should be given another try to re-submit a perfect manuscript considered acceptable,

Reviewer #3: I congratulate the authors for the revised version.

I maintain my comments on the length of the introduction and discussion. I believe the text could be better synthesized. However, I agree with the authors' arguments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Dec 2;16(12):e0260642. doi: 10.1371/journal.pone.0260642.r004

Author response to Decision Letter 1


8 Nov 2021

Comments Responses

Rev#2

General remark

Response:

Thank you for giving us the opportunity to keep improving the manuscript

Abstract

Again, please stick to Journal guidelines. Maximum word count is 300 (but NOT 399!). Please revise carefully. Remember that your answer ("Thank you for this comment, Abstract has been shortened considerably") would not seem satisfying

response: Amended. The abstract counts 267 words.

Again, please adapt aims given with the Abstract section and the questions asked in the Introduction section. This reviewer has read your comments ("Thank you for this clarification, corrections have beenamended in the Abstract page 2 lines 20-21"), but still there would be some need to polish this topic.

Response: Amended.

Remember that with your conclusions, answers must be given exclusively to your questions

Response: Amended

Introduction

Please see comments given above. Amended Page 4 lines 129-133

Materials and Methods

Heading must read "Materials and methods". Again, please stick to the Journal guidelines, and consult some recently published Plos One papers. "METHODS" would not seem acceptable. Remember that there will not be any thorough copy editing, so only flawless papers will be acceptable

Response:

Amended Page 6 line 154

As a general recommendation, please stick to Journal style with ALL other aspects. For example, you repeatedly refer to "table 2", "table 3", "table 4", and so on. Again, please consult some recently published Plos One papers, there you will see that this must read "Table (1, 2, 3, or 4)". Same with other minor aspects, please revise carefully, and remember that submitting a flawless manuscript is considered the Authors' task, and that the typesetter will not be able to copy edit your draft.

Response:

Tables, figures and supplementary information has been adapted to the journal requirements from https://journals.plos.org/plosone/s/tables

https://journals.plos.org/plosone/s/supporting-information

https://journals.plos.org/plosone/s/submission-guidelines

See highlighted marks.

Conclusions

Do not give a "summary" here. For example, "There is considerable research (...)" and "This overview summarized the information reported by 12 systematic reviews." are not considered conclusions.

Response:

Conclusions section has been amended. Page 25

Again, with your Conclusions section, please stick exclusively to your revised aims. Do not simply repeat your results here. Instead, provide a reasonable and generalizable extension of your outcome.

Response:

Conclusions section has been amended. Page 25

Same thoughts are valid for "Implications for research: (...)". These aspects surely would seem right, and should be transferable to the Discussion section. However (and again), those thoughts are not considered Conclusions. Again, please revise carefully.

Response:

Amended. Mentions to Implications for research have been moved to Discussion.

References

- Again, revise for uniform formatting. Stick to Journal style. Provide doi and PMID numbers. Again, the Authors' response ("We apologise for this inconvenience and references have been amended as suggested.") would not seem satisfying

- Example would be: "Cheng L, Weir MD, Xu HH, Antonucci JM, Lin NJ, Lin-Gibson S, et al. Effect of amorphous calcium phosphate and silver nanocomposites on dental plaque microcosm biofilms. J Biomed Mater Res B Appl Biomater. 2012; 100(5): 1378–1386. https://doi.org/10.1002/jbm.b.32709 PMID: 22566464" Revise thoroughly, but carefully. Remember that it is not the idea to re-re-review your submitted draft, and another re-submission not considered satisfying would lead to "outright rejection

Response:

Amended.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 2

Andrej M Kielbassa

15 Nov 2021

Do manual therapies have a specific autonomic effect? An overview of systematic reviews.

PONE-D-21-24377R2

Dear Dr. Roura,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards, congratulations and compliments, and stay healthy

Andrej M Kielbassa, Prof. Dr. med. dent. Dr. h. c.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The Co-Authors have satisfyingly revised their draft, according to the previous comments. All other reviewers have agreed to accept this submission, which is considered ready to proceed now.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Andrej M Kielbassa

17 Nov 2021

PONE-D-21-24377R2

Do manual therapies have a specific autonomic effect? An overview of systematic reviews

Dear Dr. Roura:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Dr. med. dent. Dr. h. c. Andrej M Kielbassa

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist

    (PDF)

    S1 Table. Search strategy.

    (DOCX)

    S2 Table. Data extraction form.

    (XLSX)

    S3 Table. Risk of bias of included reviews (complete ROBIS assessments).

    (DOCX)

    S4 Table. Concordance overlapping and conclusions.

    (DOCX)

    S5 Table. Agreements and discrepancies.

    (DOCX)

    Attachment

    Submitted filename: Responses to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES